<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T05:50:50Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5863969" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:5863969</identifier>
        <datestamp>2018-03-28</datestamp>
        <setSpec>plosone</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-id journal-id-type="pmc">plosone</journal-id>
              <journal-title-group>
                <journal-title>PLoS ONE</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1932-6203</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, CA USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC5863969</article-id>
              <article-id pub-id-type="pmcid">PMC5863969</article-id>
              <article-id pub-id-type="pmc-uid">5863969</article-id>
              <article-id pub-id-type="pmid">29566007</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pone.0194180</article-id>
              <article-id pub-id-type="publisher-id">PONE-D-17-32171</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Infectious Diseases</subject>
                    <subj-group>
                      <subject>Viral Diseases</subject>
                      <subj-group>
                        <subject>Influenza</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and life sciences</subject>
                  <subj-group>
                    <subject>Organisms</subject>
                    <subj-group>
                      <subject>Viruses</subject>
                      <subj-group>
                        <subject>RNA viruses</subject>
                        <subj-group>
                          <subject>Orthomyxoviruses</subject>
                          <subj-group>
                            <subject>Influenza Viruses</subject>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Microbiology</subject>
                    <subj-group>
                      <subject>Medical Microbiology</subject>
                      <subj-group>
                        <subject>Microbial Pathogens</subject>
                        <subj-group>
                          <subject>Viral Pathogens</subject>
                          <subj-group>
                            <subject>Orthomyxoviruses</subject>
                            <subj-group>
                              <subject>Influenza Viruses</subject>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Pathology and Laboratory Medicine</subject>
                    <subj-group>
                      <subject>Pathogens</subject>
                      <subj-group>
                        <subject>Microbial Pathogens</subject>
                        <subj-group>
                          <subject>Viral Pathogens</subject>
                          <subj-group>
                            <subject>Orthomyxoviruses</subject>
                            <subj-group>
                              <subject>Influenza Viruses</subject>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Organisms</subject>
                    <subj-group>
                      <subject>Viruses</subject>
                      <subj-group>
                        <subject>Viral Pathogens</subject>
                        <subj-group>
                          <subject>Orthomyxoviruses</subject>
                          <subj-group>
                            <subject>Influenza Viruses</subject>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Anatomy</subject>
                    <subj-group>
                      <subject>Head</subject>
                      <subj-group>
                        <subject>Face</subject>
                        <subj-group>
                          <subject>Nose</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Anatomy</subject>
                    <subj-group>
                      <subject>Head</subject>
                      <subj-group>
                        <subject>Face</subject>
                        <subj-group>
                          <subject>Nose</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Anatomy</subject>
                    <subj-group>
                      <subject>Neck</subject>
                      <subj-group>
                        <subject>Throat</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Anatomy</subject>
                    <subj-group>
                      <subject>Neck</subject>
                      <subj-group>
                        <subject>Throat</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Public and Occupational Health</subject>
                    <subj-group>
                      <subject>Global Health</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Research and Analysis Methods</subject>
                  <subj-group>
                    <subject>Bioassays and Physiological Analysis</subject>
                    <subj-group>
                      <subject>Gastrointestinal Analysis</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Research and Analysis Methods</subject>
                  <subj-group>
                    <subject>Mathematical and Statistical Techniques</subject>
                    <subj-group>
                      <subject>Statistical Methods</subject>
                      <subj-group>
                        <subject>Analysis of Variance</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Physical Sciences</subject>
                  <subj-group>
                    <subject>Mathematics</subject>
                    <subj-group>
                      <subject>Statistics (Mathematics)</subject>
                      <subj-group>
                        <subject>Statistical Methods</subject>
                        <subj-group>
                          <subject>Analysis of Variance</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and life sciences</subject>
                  <subj-group>
                    <subject>Organisms</subject>
                    <subj-group>
                      <subject>Viruses</subject>
                      <subj-group>
                        <subject>RNA viruses</subject>
                        <subj-group>
                          <subject>Orthomyxoviruses</subject>
                          <subj-group>
                            <subject>Influenza viruses</subject>
                            <subj-group>
                              <subject>Influenza A virus</subject>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and life sciences</subject>
                  <subj-group>
                    <subject>Microbiology</subject>
                    <subj-group>
                      <subject>Medical microbiology</subject>
                      <subj-group>
                        <subject>Microbial pathogens</subject>
                        <subj-group>
                          <subject>Viral pathogens</subject>
                          <subj-group>
                            <subject>Orthomyxoviruses</subject>
                            <subj-group>
                              <subject>Influenza viruses</subject>
                              <subj-group>
                                <subject>Influenza A virus</subject>
                              </subj-group>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and health sciences</subject>
                  <subj-group>
                    <subject>Pathology and laboratory medicine</subject>
                    <subj-group>
                      <subject>Pathogens</subject>
                      <subj-group>
                        <subject>Microbial pathogens</subject>
                        <subj-group>
                          <subject>Viral pathogens</subject>
                          <subj-group>
                            <subject>Orthomyxoviruses</subject>
                            <subj-group>
                              <subject>Influenza viruses</subject>
                              <subj-group>
                                <subject>Influenza A virus</subject>
                              </subj-group>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and life sciences</subject>
                  <subj-group>
                    <subject>Organisms</subject>
                    <subj-group>
                      <subject>Viruses</subject>
                      <subj-group>
                        <subject>Viral pathogens</subject>
                        <subj-group>
                          <subject>Orthomyxoviruses</subject>
                          <subj-group>
                            <subject>Influenza viruses</subject>
                            <subj-group>
                              <subject>Influenza A virus</subject>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Performance of the inFLUenza Patient-Reported Outcome (FLU-PRO) diary in patients with influenza-like illness (ILI)</article-title>
                <alt-title alt-title-type="running-head">FLU-PRO validation in ILI patients</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-5150-5119</contrib-id>
                  <name>
                    <surname>Powers</surname>
                    <given-names>John H.</given-names>
                    <suffix>III</suffix>
                  </name>
                  <role content-type="http://credit.casrai.org/">Conceptualization</role>
                  <role content-type="http://credit.casrai.org/">Data curation</role>
                  <role content-type="http://credit.casrai.org/">Formal analysis</role>
                  <role content-type="http://credit.casrai.org/">Funding acquisition</role>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Project administration</role>
                  <role content-type="http://credit.casrai.org/">Resources</role>
                  <role content-type="http://credit.casrai.org/">Supervision</role>
                  <role content-type="http://credit.casrai.org/">Validation</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="corresp" rid="cor001">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bacci</surname>
                    <given-names>Elizabeth D.</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Conceptualization</role>
                  <role content-type="http://credit.casrai.org/">Data curation</role>
                  <role content-type="http://credit.casrai.org/">Formal analysis</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Project administration</role>
                  <role content-type="http://credit.casrai.org/">Validation</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Leidy</surname>
                    <given-names>Nancy K.</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Conceptualization</role>
                  <role content-type="http://credit.casrai.org/">Formal analysis</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Supervision</role>
                  <role content-type="http://credit.casrai.org/">Validation</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Poon</surname>
                    <given-names>Jiat-Ling</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Data curation</role>
                  <role content-type="http://credit.casrai.org/">Formal analysis</role>
                  <role content-type="http://credit.casrai.org/">Project administration</role>
                  <role content-type="http://credit.casrai.org/">Validation</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Stringer</surname>
                    <given-names>Sonja</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Data curation</role>
                  <role content-type="http://credit.casrai.org/">Formal analysis</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Project administration</role>
                  <role content-type="http://credit.casrai.org/">Supervision</role>
                  <role content-type="http://credit.casrai.org/">Validation</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Memoli</surname>
                    <given-names>Matthew J.</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Data curation</role>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Resources</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff004">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Han</surname>
                    <given-names>Alison</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Data curation</role>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Resources</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff004">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Fairchok</surname>
                    <given-names>Mary P.</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Data curation</role>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Resources</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff005">
                    <sup>5</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff006">
                    <sup>6</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff007">
                    <sup>7</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Coles</surname>
                    <given-names>Christian</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Data curation</role>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Project administration</role>
                  <role content-type="http://credit.casrai.org/">Resources</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff006">
                    <sup>6</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff007">
                    <sup>7</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Owens</surname>
                    <given-names>Jackie</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Project administration</role>
                  <role content-type="http://credit.casrai.org/">Resources</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff006">
                    <sup>6</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff007">
                    <sup>7</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Chen</surname>
                    <given-names>Wei-Ju</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Formal analysis</role>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Resources</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff006">
                    <sup>6</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff007">
                    <sup>7</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Arnold</surname>
                    <given-names>John C.</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Project administration</role>
                  <role content-type="http://credit.casrai.org/">Resources</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <xref ref-type="aff" rid="aff008">
                    <sup>8</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Danaher</surname>
                    <given-names>Patrick J.</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Resources</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff009">
                    <sup>9</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lalani</surname>
                    <given-names>Tahaniyat</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Resources</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff007">
                    <sup>7</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff010">
                    <sup>10</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Burgess</surname>
                    <given-names>Timothy H.</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Resources</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff006">
                    <sup>6</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff011">
                    <sup>11</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Millar</surname>
                    <given-names>Eugene V.</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff006">
                    <sup>6</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff007">
                    <sup>7</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ridore</surname>
                    <given-names>Michelande</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Resources</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <xref ref-type="aff" rid="aff012">
                    <sup>12</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hernández</surname>
                    <given-names>Andrés</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff013">
                    <sup>13</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Rodríguez-Zulueta</surname>
                    <given-names>Patricia</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Resources</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <xref ref-type="aff" rid="aff014">
                    <sup>14</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ortega-Gallegos</surname>
                    <given-names>Hilda</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Resources</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <xref ref-type="aff" rid="aff015">
                    <sup>15</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Galindo-Fraga</surname>
                    <given-names>Arturo</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Resources</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff015">
                    <sup>15</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ruiz-Palacios</surname>
                    <given-names>Guillermo M.</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Resources</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff015">
                    <sup>15</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Pett</surname>
                    <given-names>Sarah</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Resources</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff016">
                    <sup>16</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff017">
                    <sup>17</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff018">
                    <sup>18</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff019">
                    <sup>19</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff020">
                    <sup>20</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Fischer</surname>
                    <given-names>William</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Resources</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff017">
                    <sup>17</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff021">
                    <sup>21</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gillor</surname>
                    <given-names>Daniel</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Resources</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff017">
                    <sup>17</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff022">
                    <sup>22</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Moreno Macias</surname>
                    <given-names>Laura</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Resources</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <xref ref-type="aff" rid="aff017">
                    <sup>17</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff023">
                    <sup>23</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>DuVal</surname>
                    <given-names>Anna</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Resources</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff024">
                    <sup>24</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Rothman</surname>
                    <given-names>Richard</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Resources</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <xref ref-type="aff" rid="aff024">
                    <sup>24</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Dugas</surname>
                    <given-names>Andrea</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Resources</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff024">
                    <sup>24</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Guerrero</surname>
                    <given-names>M. Lourdes</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Conceptualization</role>
                  <role content-type="http://credit.casrai.org/">Data curation</role>
                  <role content-type="http://credit.casrai.org/">Formal analysis</role>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Resources</role>
                  <role content-type="http://credit.casrai.org/">Supervision</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff015">
                    <sup>15</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="aff001">
                <label>1</label>
                <addr-line>Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc., NCI Campus at Frederick, Frederick, MD, United States of America</addr-line>
              </aff>
              <aff id="aff002">
                <label>2</label>
                <addr-line>Evidera Evidence, Value &amp; Access by PPD, Seattle, WA, United States of America</addr-line>
              </aff>
              <aff id="aff003">
                <label>3</label>
                <addr-line>Evidera Evidence, Value &amp; Access by PPD, Bethesda, MD, United States of America</addr-line>
              </aff>
              <aff id="aff004">
                <label>4</label>
                <addr-line>National Institutes of Allergy and Infectious Diseases, NIH, Bethesda, MD, United States of America</addr-line>
              </aff>
              <aff id="aff005">
                <label>5</label>
                <addr-line>Madigan Army Medical Center, Fort Lewis, WA, United States of America</addr-line>
              </aff>
              <aff id="aff006">
                <label>6</label>
                <addr-line>Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, United States of America</addr-line>
              </aff>
              <aff id="aff007">
                <label>7</label>
                <addr-line>Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, MD, United States of America</addr-line>
              </aff>
              <aff id="aff008">
                <label>8</label>
                <addr-line>Naval Medical Center, San Diego, CA, United States of America</addr-line>
              </aff>
              <aff id="aff009">
                <label>9</label>
                <addr-line>Defense Institute for Medical Operations, San Antonio, TX, United States of America</addr-line>
              </aff>
              <aff id="aff010">
                <label>10</label>
                <addr-line>Naval Medical Center, Portsmouth, VA, United States of America</addr-line>
              </aff>
              <aff id="aff011">
                <label>11</label>
                <addr-line>Walter Reed National Military Medical Center, Bethesda, MD, United States of America</addr-line>
              </aff>
              <aff id="aff012">
                <label>12</label>
                <addr-line>Children’s National Medical Center, Washington, DC, United States of America</addr-line>
              </aff>
              <aff id="aff013">
                <label>13</label>
                <addr-line>Instituto Nacional de Enfermedades Infecciosas, Mexico City, Mexico</addr-line>
              </aff>
              <aff id="aff014">
                <label>14</label>
                <addr-line>Hospital General Dr. Manuel Gea González, Mexico City, Mexico</addr-line>
              </aff>
              <aff id="aff015">
                <label>15</label>
                <addr-line>Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico</addr-line>
              </aff>
              <aff id="aff016">
                <label>16</label>
                <addr-line>UCL, London, United Kingdom</addr-line>
              </aff>
              <aff id="aff017">
                <label>17</label>
                <addr-line>INSIGHT Influenza Study Groups, Rochester, MN, United States of America</addr-line>
              </aff>
              <aff id="aff018">
                <label>18</label>
                <addr-line>Institute of Clinical Trials and Methodology, University College, London, United Kingdom</addr-line>
              </aff>
              <aff id="aff019">
                <label>19</label>
                <addr-line>Institute for Global Health, University College, London, United Kingdom</addr-line>
              </aff>
              <aff id="aff020">
                <label>20</label>
                <addr-line>Kirby Institute, University of New South Wales, Kensington, Australia</addr-line>
              </aff>
              <aff id="aff021">
                <label>21</label>
                <addr-line>University of North Carolina, Chapel Hill, NC, United States of America</addr-line>
              </aff>
              <aff id="aff022">
                <label>22</label>
                <addr-line>University of Cologne, Cologne, Germany</addr-line>
              </aff>
              <aff id="aff023">
                <label>23</label>
                <addr-line>Hospital General de Agudos JM Ramos Mejia, Buenos Aires, Argentina</addr-line>
              </aff>
              <aff id="aff024">
                <label>24</label>
                <addr-line>Johns Hopkins University School of Medicine, Baltimore, MD, United States of America</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Ortiz</surname>
                    <given-names>Justin R.</given-names>
                  </name>
                  <role>Editor</role>
                  <xref ref-type="aff" rid="edit1"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">
                <addr-line>University of Washington, UNITED STATES</addr-line>
              </aff>
              <author-notes>
                <fn fn-type="COI-statement" id="coi001">
                  <p><bold>Competing Interests: </bold>ED Bacci, NK Leidy, JL Poon, and S Stringer, are salaried employees of Evidera Evidence, Value &amp; Access by PPD (Evidera). JH Powers is an employee of Leidos Biomedical Research. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The view(s) expressed in this article are those of the author(s) and do not reflect the official policy or position of Uniformed Services University of the Health Sciences, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., National Institutes of Health or the Department of Health and Human Services, Brooke Army Medical Center, Walter Reed National Military Medical Center, Landstuhl Regional Medical Center, the US Army Medical Department, the US Army Office of the Surgeon General, the Department of the Air Force, the Department of the Navy, the Department of the Army or the Department of Defense or the US Government. Mention of trade names, commercial products, or organizations does not imply endorsement by the US Government.</p>
                </fn>
                <corresp id="cor001">* E-mail: <email>john.powers@nih.gov</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>22</day>
                <month>3</month>
                <year>2018</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2018</year>
              </pub-date>
              <volume>13</volume>
              <issue>3</issue>
              <elocation-id>e0194180</elocation-id>
              <history>
                <date date-type="received">
                  <day>1</day>
                  <month>9</month>
                  <year>2017</year>
                </date>
                <date date-type="accepted">
                  <day>26</day>
                  <month>2</month>
                  <year>2018</year>
                </date>
              </history>
              <permissions>
                <license xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">
                  <license-p>This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0</ext-link> public domain dedication.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="pone.0194180.pdf"/>
              <abstract>
                <sec id="sec001">
                  <title>Background</title>
                  <p>The inFLUenza Patient Reported Outcome (FLU-PRO) measure is a daily diary assessing signs/symptoms of influenza across six body systems: Nose, Throat, Eyes, Chest/Respiratory, Gastrointestinal, Body/Systemic, developed and tested in adults with influenza.</p>
                </sec>
                <sec id="sec002">
                  <title>Objectives</title>
                  <p>This study tested the reliability, validity, and responsiveness of FLU-PRO scores in adults with influenza-like illness (ILI).</p>
                </sec>
                <sec id="sec003">
                  <title>Methods</title>
                  <p>Data from the prospective, observational study used to develop and test the FLU-PRO in influenza virus positive patients were analyzed. Adults (<underline>≥</underline>18 years) presenting with influenza symptoms in outpatient settings in the US, UK, Mexico, and South America were enrolled, tested for influenza virus, and asked to complete the 37-item draft FLU-PRO daily for up to 14-days. Analyses were performed on data from patients testing negative. Reliability of the final, 32-item FLU-PRO was estimated using Cronbach’s alpha (α; Day 1) and intraclass correlation coefficients (ICC; 2-day reproducibility). Convergent and known-groups validity were assessed using patient global assessments of influenza severity (PGA). Patient report of return to usual health was used to assess responsiveness (Day 1–7).</p>
                </sec>
                <sec id="sec004">
                  <title>Results</title>
                  <p>The analytical sample included 220 ILI patients (mean age = 39.3, 64.1% female, 88.6% white). Sixty-one (28%) were hospitalized at some point in their illness. Internal consistency reliability (α) of FLU-PRO Total score was 0.90 and ranged from 0.72–0.86 for domain scores. Reproducibility (Day 1–2) was 0.64 for Total, ranging from 0.46–0.78 for domain scores. Day 1 FLU-PRO scores correlated (≥0.30) with the PGA (except Gastrointestinal) and were significantly different across PGA severity groups (Total: F = 81.7, p&lt;0.001; subscales: F = 6.9–62.2; p&lt;0.01). Mean score improvements Day 1–7 were significantly greater in patients reporting return to usual health compared with those who did not (p&lt;0.05, Total and subscales, except Gastrointestinal and Eyes).</p>
                </sec>
                <sec id="sec005">
                  <title>Conclusions</title>
                  <p>Results suggest FLU-PRO scores are reliable, valid, and responsive in adults with influenza-like illness.</p>
                </sec>
              </abstract>
              <funding-group>
                <award-group id="award001">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000002</institution-id>
                      <institution>National Institutes of Health</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>Contract No. HHSN261200800001E</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-5150-5119</contrib-id>
                    <name>
                      <surname>Powers</surname>
                      <given-names>John H.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <funding-statement>This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. This research was supported in part by the Intramural Research Program of the NIH, NIAID. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This study was supported by the Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) program executed through the Uniformed Services University of the Health Sciences (USUHS). This project has been funded in whole, or in part, with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), under Inter-Agency Agreement (#64019). ED Bacci, NK Leidy, JL Poon, and S Stringer, are salaried employees of Evidera Evidence, Value &amp; Access by PPD (Evidera). Evidera received funding (in whole or in part with federal funds) from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E, to conduct the study and develop this manuscript. JH Powers is an employee of Leidos Biomedical Research under a Federally Funded Research and Development Contract (FFRDC) between Leidos and the National Institutes of Health. Leidos (JHP) and Evidera (EDB, NKL, JLP, SS) provided support in the form of salaries for the above noted authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section. S Pett has received funding from the Medical Research Council, UK.</funding-statement>
              </funding-group>
              <counts>
                <fig-count count="1"/>
                <table-count count="6"/>
                <page-count count="15"/>
              </counts>
              <custom-meta-group>
                <custom-meta id="data-availability">
                  <meta-name>Data Availability</meta-name>
                  <meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <title>Data Availability</title>
              <p>All relevant data are within the paper and its Supporting Information files.</p>
            </notes>
          </front>
          <body>
            <sec sec-type="intro" id="sec006">
              <title>Introduction</title>
              <p>Influenza (flu) is characterized by an array of symptoms, including chills, cough, sore throat, runny or stuffy nose, fatigue, muscle/body aches, and potentially diarrhea and vomiting, with symptoms ranging in severity and duration [<xref rid="pone.0194180.ref001" ref-type="bibr">1</xref>]. In the absence of known influenza virus, this constellation of symptoms can be caused by a variety of other viruses and is often diagnosed as influenza-like illness (ILI) [<xref rid="pone.0194180.ref002" ref-type="bibr">2</xref>]. While most patients recover from ILI, the symptoms can negatively impact daily activities and functioning. Symptoms of ILI often closely approximate influenza symptoms such that the two previously have been indistinguishable. Therefore, a symptom measure useful in influenza may also be useful for evaluating the presence and severity of symptoms of ILI.</p>
              <p>The InFLUenza Patient-Reported Outcome (FLU-PRO) measure was designed to evaluate the presence, severity, and duration of influenza symptoms in clinical trials. Developed using good research practices for scale development methods [<xref rid="pone.0194180.ref003" ref-type="bibr">3</xref>–<xref rid="pone.0194180.ref005" ref-type="bibr">5</xref>], including those recommended by the US Food and Drug Administration (FDA) [<xref rid="pone.0194180.ref006" ref-type="bibr">6</xref>], this 32-item daily diary offers a comprehensive evaluation of symptoms commonly experienced by patients with influenza that can be completed in ≤5 minutes. While other measures of influenza symptom severity exist, such as the Flu-iiQ [<xref rid="pone.0194180.ref007" ref-type="bibr">7</xref>] and the Canadian Acute Respiratory Illness and Flu Scale (CARIFS) [<xref rid="pone.0194180.ref008" ref-type="bibr">8</xref>], these measures do not assess the full range of symptoms associated with varied strains of influenza and identified as important to the patients themselves [<xref rid="pone.0194180.ref009" ref-type="bibr">9</xref>]. Additionally, the CARIFS was developed for use in children, while the FLU-PRO was developed for studies of adults and children, with content validity shown in both groups [<xref rid="pone.0194180.ref009" ref-type="bibr">9</xref>]. Previous research demonstrated that the FLU-PRO is reliable, valid, and responsive to change in hospitalized and non-hospitalized adults with laboratory-confirmed influenza [<xref rid="pone.0194180.ref010" ref-type="bibr">10</xref>]. The purpose of these analyses was to test the reliability, validity, and responsiveness of FLU-PRO scores in patients with influenza symptoms and testing negative for the influenza virus.</p>
            </sec>
            <sec sec-type="materials|methods" id="sec007">
              <title>Materials and methods</title>
              <sec id="sec008">
                <title>Study design</title>
                <p>Data from the prospective, observational FLU-PRO development study conducted with informed consent, under the National Institute of Allergy and Infectious Diseases institutional review board approval, and in accordance with the Declaration of Helsinki, were used in these analyses. Methods and results of the primary analyses in those with laboratory-confirmed influenza are reported elsewhere [<xref rid="pone.0194180.ref010" ref-type="bibr">10</xref>].</p>
                <p>Briefly, adults ≥18 years of age seeking medical care for acute influenza symptoms at participating clinics in the US (16 sites; English-speaking), Argentina (two sites; Spanish-speaking), United Kingdom (one site; English-speaking), and Mexico (three sites; Spanish-speaking) were recruited during clinic visits. An elevated body temperature of 100°F [37.8°C] or greater was not an enrollment requirement. All study participants were tested for influenza using rapid influenza diagnostic tests (RIDTs), including polymerase chain reaction, rapid antigen test, and/or viral culture by nasal or nasopharyngeal swab. The performance of the FLU-PRO in those testing positive are presented elsewhere [<xref rid="pone.0194180.ref010" ref-type="bibr">10</xref>]. Data from subjects testing negative for the influenza virus were included in the current analysis.</p>
                <p>In addition to the influenza diagnostic test, consented patients completed assessments of sociodemographic and clinical characteristics at baseline and a daily diary for 14 days that included the 37-item draft FLU-PRO symptom diary and nine additional questions used for FLU-PRO validation. At the Mexico site, the diary was completed via telephone interview with data entered directly into a web-based portal by the interviewer. Patients in 16 US sites, one UK site, and one Argentina site completed the survey either via interviewer-administration or self-administration via a web-based system using the subject’s personal web-enabled device.</p>
              </sec>
              <sec id="sec009">
                <title>Compliance with ethical standards</title>
                <p>The studies were conducted in accordance with the Declaration of Helsinki, and the National Institute of Allergy and Infectious Diseases ethics committee/institutional review board requirements, and good clinical practice guidelines. Informed consent was obtained from all individual participants included in the study.</p>
              </sec>
              <sec id="sec010">
                <title>Instruments: Patient-reported Outcomes (PROs)</title>
                <sec id="sec011">
                  <title>InFLUenza Patient-Reported Outcome (FLU-PRO)</title>
                  <p>The final FLU-PRO questionnaire instructed respondents to rate the severity of 32 influenza symptoms over the past 24 hours. The presence and severity of influenza signs and symptoms are assessed across six body systems affected by influenza: Nose (4 items), Throat (3 items), Eyes (3 items), Chest/Respiratory (7 items), Gastrointestinal (4 items), and Body/Systemic (11 items). A total score quantifies symptoms overall. Respondents are asked to rate each sign or symptom on a 5-point ordinal severity scale, with higher scores indicating a more severe sign or symptom. The questionnaire was developed for self-report or interviewer-administration, with slight differences in the instructions applicable for each administration.</p>
                  <p>Development procedures addressing content validity of the FLU-PRO are described elsewhere [<xref rid="pone.0194180.ref009" ref-type="bibr">9</xref>]. Quantitative item reduction and validation testing were performed on data from a prospective validation study, with data from laboratory-confirmed influenza positive patients (N = 221) serving as the primary analytical sample [<xref rid="pone.0194180.ref010" ref-type="bibr">10</xref>].</p>
                </sec>
                <sec id="sec012">
                  <title>Patient Global Assessments (PGA)</title>
                  <p>The Patient Global Rating of Flu Severity is a single item to assess participants’ overall influenza symptom severity. Participants were asked to rate severity on the following scale: 0 (“No flu symptoms today”), 1 (“Mild”), 2 (“Moderate”), 3 (“Severe”), and 4 (“Very severe”). The Patient Global Assessment of Interference in Daily Activities is a single item to assess interference in daily activities due to influenza symptoms during that day. Participants rated interference on the following scale: 1 (“Not at all”), 2 (“A little bit”), 3 (“Somewhat”), 4 (“Quite a bit”), and 5 (“Very much”). The Patient Global Assessment of Health is a single item to assess general physical health during that day. Participants rated their physical health on the following scale: 1 (“Poor”), 2 (“Fair”), 3 (“Good”), 4 (“Very good”), and 5 (“Excellent”). Finally, a Patient Global Rating of Change in Flu Severity was used to identify stable patients for reproducibility assessment.</p>
                </sec>
                <sec id="sec013">
                  <title>Return to “usual” health and activities</title>
                  <p>Patients were asked to respond (yes/no) to the following questions: “Have you returned to your usual health today?” and “Have you returned to your usual activities today?”</p>
                </sec>
              </sec>
              <sec id="sec014">
                <title>Statistical analyses</title>
                <p>Statistical tests were performed in accordance with classical test theory [<xref rid="pone.0194180.ref011" ref-type="bibr">11</xref>] to evaluate the psychometric properties of the FLU-PRO total and domain scores in participants with ILI, including reliability, construct and known-groups validity, and responsiveness. These analyses were performed on the entire ILI cohort and stratified by hospitalization status.</p>
                <sec id="sec015">
                  <title>Reliability (internal and test-retest)</title>
                  <p>Cronbach’s coefficient alpha was used to estimate internal consistency reliability of the FLU-PRO Total and domain scores on day 1. Coefficients of 0.7–0.9 were pre-specified as “good” internal consistency, 0.4–&lt;0.7 as moderate, and &lt;0.4 as low or poor [<xref rid="pone.0194180.ref011" ref-type="bibr">11</xref>,<xref rid="pone.0194180.ref012" ref-type="bibr">12</xref>].</p>
                  <p>Data from patients whose influenza severity was unchanged over time were used to estimate the test-retest reliability of FLU-PRO Total and domain scores. Stable subjects were defined as those with “no change” on the Patient Global Rating of Change in Flu Severity over two consecutive days during Week 1 (i.e., day 1 to day 2, day 2 to day 3, etc.). If a subject was missing FLU-PRO scores for one of the days in the planned comparison, data for this subject was excluded from that analytical pair. Intraclass correlation coefficients (ICC from a fixed-effects model), paired <italic>t</italic>-tests, and effect size (ES) were calculated to evaluate score reliability. ICCs were expected to be at least moderate, exceeding 0.60. Mean differences between the two observations were expected to be minimal with a small ES (&lt;0.20).</p>
                </sec>
                <sec id="sec016">
                  <title>Construct validity</title>
                  <p>The relationship between the FLU-PRO Total and domain scores and three global ratings were assessed using Spearman correlations (<italic>r</italic><sub><italic>s</italic></sub>) using day 1 data, hypothesizing that the relationship between FLU-PRO scores and these global ratings would be moderate to high (<italic>r</italic><sub><italic>s</italic></sub> &gt;0.30) [<xref rid="pone.0194180.ref013" ref-type="bibr">13</xref>]. Correlations with the Patient Global Rating of Flu Severity were hypothesized to be strongest, while weaker correlations were expected with the more distal constructs, including the Patient Global Rating of Physical Health and the Patient Global Assessment of Interference with Daily Activities.</p>
                </sec>
                <sec id="sec017">
                  <title>Known-groups validity</title>
                  <p>Analysis of variance (ANOVA) was used to compare FLU-PRO Total and domain scores across three Patient Global Rating of Flu Severity categories at day 1: “None” or “Mild”; “Moderate”; and “Severe” or “Very severe”. Mean (SD), <italic>F</italic>-scores, and p-values were reported to determine the magnitude of the differences. Pairwise comparisons between means were performed using Scheffe’s test adjusting for multiple comparisons.</p>
                </sec>
                <sec id="sec018">
                  <title>Responsiveness</title>
                  <p>Analysis of covariance (ANCOVA) was used to compare changes in FLU-PRO scores at day 7 in responders (those returning to usual health or activity) and non-responders (those not returning to usual health or activity), adjusting for day 1 scores. Responders were defined using the two different anchors in two separate analyses. It was expected that responders would have significantly larger (p &lt;0.05) change scores than non-responders.</p>
                </sec>
                <sec id="sec019">
                  <title>Exploratory analyses</title>
                  <p>Exploratory analyses were conducted to statistically compare the symptom profiles of ILI patients in the current analytic sample at day 1 to the influenza positive patients in the FLU-PRO development sample. Specifically, independent samples <italic>t-</italic>tests were used to compare mean FLU-PRO total and domain scores between all ILI patients overall (i.e., hospitalized, and non-hospitalized) versus all influenza positive patients overall, while a 2-way analysis of variance (ANOVA) was used to compare mean FLU-PRO scores by influenza (i.e., positive, and negative) and hospitalization (i.e., hospitalized, and non-hospitalized) status. Scheffe’s test was used to assess pairwise comparisons between groups.</p>
                </sec>
              </sec>
            </sec>
            <sec sec-type="results" id="sec020">
              <title>Results</title>
              <sec id="sec021">
                <title>Sample</title>
                <p>Of the 536 subjects enrolled in the study, 441 had the minimum required data (day 1 diary assessment and ≥1 post-day 1 diary entry); data from the 220 subjects testing negative for the influenza virus were used in the current study. <xref ref-type="table" rid="pone.0194180.t001">Table 1</xref> presents baseline demographic and clinical characteristics for the analytical sample. The majority of the participants (70.9%) were from non-US countries.</p>
                <table-wrap id="pone.0194180.t001" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0194180.t001</object-id>
                  <label>Table 1</label>
                  <caption>
                    <title>Patient demographic characteristics by region in patients with influenza like illness (N = 220).</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0194180.t001g" xlink:href="pone.0194180.t001"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="2" colspan="1">Variable</th>
                          <th align="center" colspan="2" rowspan="1">Day 1</th>
                        </tr>
                        <tr>
                          <th align="center" rowspan="1" colspan="1">USA<break/>(n = 64)</th>
                          <th align="center" rowspan="1" colspan="1">Other Countries<xref ref-type="table-fn" rid="t001fn001"><sup>1</sup></xref><break/>(n = 156)</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Age, Years</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Mean (SD)</td>
                          <td align="center" rowspan="1" colspan="1">32.7 (13.0)</td>
                          <td align="center" rowspan="1" colspan="1">42.1 (15.1)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Median (Min-Max)</td>
                          <td align="center" rowspan="1" colspan="1">27.5 (19–67)</td>
                          <td align="center" rowspan="1" colspan="1">39.0 (20–91)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    &gt;65</td>
                          <td align="center" rowspan="1" colspan="1">1 (1.6%)</td>
                          <td align="center" rowspan="1" colspan="1">12 (7.7%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Sex, n (%)</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Female</td>
                          <td align="center" rowspan="1" colspan="1">41 (64.1%)</td>
                          <td align="center" rowspan="1" colspan="1">100 (64.1%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Ethnicity, n (%)</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Hispanic or Latino</td>
                          <td align="center" rowspan="1" colspan="1">5 (7.8%)</td>
                          <td align="center" rowspan="1" colspan="1">152 (97.4%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Not Hispanic or Latino</td>
                          <td align="center" rowspan="1" colspan="1">59 (92.2%)</td>
                          <td align="center" rowspan="1" colspan="1">4 (2.6%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Race, n (%)</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Asian</td>
                          <td align="center" rowspan="1" colspan="1">2 (3.1%)</td>
                          <td align="center" rowspan="1" colspan="1">0 (0%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Black or African American</td>
                          <td align="center" rowspan="1" colspan="1">21 (32.8%)</td>
                          <td align="center" rowspan="1" colspan="1">0 (0%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    White or Caucasian (Mestizo)</td>
                          <td align="center" rowspan="1" colspan="1">0 (0%)</td>
                          <td align="center" rowspan="1" colspan="1">152 (97.4%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    White</td>
                          <td align="center" rowspan="1" colspan="1">39 (60.9%)</td>
                          <td align="center" rowspan="1" colspan="1">4 (2.6%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Other</td>
                          <td align="center" rowspan="1" colspan="1">2 (3.1%)</td>
                          <td align="center" rowspan="1" colspan="1">0 (0%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Employment Status, n (%)</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Employed, full time</td>
                          <td align="center" rowspan="1" colspan="1">19 (29.7%)</td>
                          <td align="center" rowspan="1" colspan="1">81 (51.9%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Employed, part-time</td>
                          <td align="center" rowspan="1" colspan="1">0 (0%)</td>
                          <td align="center" rowspan="1" colspan="1">20 (12.8%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Homemaker</td>
                          <td align="center" rowspan="1" colspan="1">1 (1.6%)</td>
                          <td align="center" rowspan="1" colspan="1">23 (14.7%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Student</td>
                          <td align="center" rowspan="1" colspan="1">0 (0%)</td>
                          <td align="center" rowspan="1" colspan="1">13 (8.3%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Unemployed</td>
                          <td align="center" rowspan="1" colspan="1">0 (0%)</td>
                          <td align="center" rowspan="1" colspan="1">11 (7.1%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Retired</td>
                          <td align="center" rowspan="1" colspan="1">0 (0%)</td>
                          <td align="center" rowspan="1" colspan="1">1 (0.6%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Disabled</td>
                          <td align="center" rowspan="1" colspan="1">0 (0%)</td>
                          <td align="center" rowspan="1" colspan="1">3 (1.9%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Other</td>
                          <td align="center" rowspan="1" colspan="1">0 (0%)</td>
                          <td align="center" rowspan="1" colspan="1">2 (1.3%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Missing</td>
                          <td align="center" rowspan="1" colspan="1">44 (68.8%)</td>
                          <td align="center" rowspan="1" colspan="1">2 (1.3%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Military Status, n (%)</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Never in the military</td>
                          <td align="center" rowspan="1" colspan="1">0 (0%)</td>
                          <td align="center" rowspan="1" colspan="1">153 (98.1%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Active</td>
                          <td align="center" rowspan="1" colspan="1">16 (25.0%)</td>
                          <td align="center" rowspan="1" colspan="1">0 (0%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Retired</td>
                          <td align="center" rowspan="1" colspan="1">1 (1.6%)</td>
                          <td align="center" rowspan="1" colspan="1">0 (0%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Reserves</td>
                          <td align="center" rowspan="1" colspan="1">0 (0%)</td>
                          <td align="center" rowspan="1" colspan="1">1 (0.6%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Other</td>
                          <td align="center" rowspan="1" colspan="1">1 (1.6%)</td>
                          <td align="center" rowspan="1" colspan="1">0 (0%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Missing</td>
                          <td align="center" rowspan="1" colspan="1">46 (71.9%)</td>
                          <td align="center" rowspan="1" colspan="1">2 (1.3%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Highest Level of Education</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Elementary/primary school</td>
                          <td align="center" rowspan="1" colspan="1">0 (0%)</td>
                          <td align="center" rowspan="1" colspan="1">15 (9.6%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Secondary/high school</td>
                          <td align="center" rowspan="1" colspan="1">5 (7.8%)</td>
                          <td align="center" rowspan="1" colspan="1">54 (34.6%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Some college</td>
                          <td align="center" rowspan="1" colspan="1">7 (10.9%)</td>
                          <td align="center" rowspan="1" colspan="1">8 (5.1%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    College degree</td>
                          <td align="center" rowspan="1" colspan="1">4 (6.3%)</td>
                          <td align="center" rowspan="1" colspan="1">55 (35.3%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Postgraduate degree</td>
                          <td align="center" rowspan="1" colspan="1">5 (7.8%)</td>
                          <td align="center" rowspan="1" colspan="1">13 (8.3%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Other</td>
                          <td align="center" rowspan="1" colspan="1">43 (67.2%)</td>
                          <td align="center" rowspan="1" colspan="1">11 (7.1%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Current Treatments, n (%)</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Oseltamivir (Tamiflu)</td>
                          <td align="center" rowspan="1" colspan="1">4 (6.3%)</td>
                          <td align="center" rowspan="1" colspan="1">17 (10.9%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Amantadine (Symmetrel)</td>
                          <td align="center" rowspan="1" colspan="1">0 (0%)</td>
                          <td align="center" rowspan="1" colspan="1">6 (3.8%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Other</td>
                          <td align="center" rowspan="1" colspan="1">15 (23.4%)</td>
                          <td align="center" rowspan="1" colspan="1">93 (59.6%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    None</td>
                          <td align="center" rowspan="1" colspan="1">45 (70.3%)</td>
                          <td align="center" rowspan="1" colspan="1">52 (33.3%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Co-morbidities, n (%)</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    None</td>
                          <td align="center" rowspan="1" colspan="1">44 (68.8%)</td>
                          <td align="center" rowspan="1" colspan="1">67 (42.9%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Asthma</td>
                          <td align="center" rowspan="1" colspan="1">8 (12.5%)</td>
                          <td align="center" rowspan="1" colspan="1">14 (9.0%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Chronic Obstructive Pulmonary Disease (COPD)</td>
                          <td align="center" rowspan="1" colspan="1">0 (0%)</td>
                          <td align="center" rowspan="1" colspan="1">3 (1.9%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Osteoporosis</td>
                          <td align="center" rowspan="1" colspan="1">0 (0%)</td>
                          <td align="center" rowspan="1" colspan="1">4 (2.6%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Depression</td>
                          <td align="center" rowspan="1" colspan="1">1 (1.6%)</td>
                          <td align="center" rowspan="1" colspan="1">14 (9.0%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Hypertension</td>
                          <td align="center" rowspan="1" colspan="1">2 (3.1%)</td>
                          <td align="center" rowspan="1" colspan="1">28 (17.9%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Raised cholesterol</td>
                          <td align="center" rowspan="1" colspan="1">1 (1.6%)</td>
                          <td align="center" rowspan="1" colspan="1">18 (11.5%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Stomach ulcers</td>
                          <td align="center" rowspan="1" colspan="1">0 (0%)</td>
                          <td align="center" rowspan="1" colspan="1">5 (3.2%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Heart attack/angina</td>
                          <td align="center" rowspan="1" colspan="1">0 (0%)</td>
                          <td align="center" rowspan="1" colspan="1">5 (3.2%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Diabetes</td>
                          <td align="center" rowspan="1" colspan="1">3 (4.7%)</td>
                          <td align="center" rowspan="1" colspan="1">20 (12.8%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Kidney disease</td>
                          <td align="center" rowspan="1" colspan="1">2 (3.1%)</td>
                          <td align="center" rowspan="1" colspan="1">10 (6.4%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Lung disease</td>
                          <td align="center" rowspan="1" colspan="1">0 (0%)</td>
                          <td align="center" rowspan="1" colspan="1">8 (5.1%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Tuberculosis</td>
                          <td align="center" rowspan="1" colspan="1">0 (0%)</td>
                          <td align="center" rowspan="1" colspan="1">3 (1.9%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Other</td>
                          <td align="center" rowspan="1" colspan="1">6 (9.4%)</td>
                          <td align="center" rowspan="1" colspan="1">46 (29.5%)</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t001fn001">
                      <p><sup>1</sup>Other countries include Mexico (n = 154), Argentina (n = 1), and UK (n = 1).</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="sec022">
                <title>Evaluation of psychometric properties</title>
                <p>Results for the entire sample are reported below; results stratified by hospitalization status are provided in the online supplement <xref ref-type="supplementary-material" rid="pone.0194180.s001">S1 File</xref>.</p>
                <sec id="sec023">
                  <title>Descriptive statistics of FLU-PRO domain and Total scores</title>
                  <p>The distributional characteristics of the FLU-PRO domain and Total scores on day 1 are shown in <xref ref-type="table" rid="pone.0194180.t002">Table 2</xref>. Mean domain scores were lowest for the Gastrointestinal domain (mean = 0.5; SD = 0.7) and highest for the Nose (mean = 1.5; SD = 1.0) and Throat (mean = 1.5; SD = 1.2) domains. Floor effects were found for the Gastrointestinal (47%) domain. No ceiling effects were found.</p>
                  <table-wrap id="pone.0194180.t002" orientation="portrait" position="float">
                    <object-id pub-id-type="doi">10.1371/journal.pone.0194180.t002</object-id>
                    <label>Table 2</label>
                    <caption>
                      <title>FLU-PRO domain and total score descriptive statistics Day 1.</title>
                    </caption>
                    <alternatives>
                      <graphic id="pone.0194180.t002g" xlink:href="pone.0194180.t002"/>
                      <table frame="hsides" rules="groups">
                        <colgroup span="1">
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                        </colgroup>
                        <thead>
                          <tr>
                            <th align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/>
                            <th align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">N</th>
                            <th align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">Mean ± SD</th>
                            <th align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">Range, Median (Mode)</th>
                            <th align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">Floor<break/>n (%)</th>
                            <th align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">Ceiling<break/>n (%)</th>
                            <th align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">Missing<break/>n (%)</th>
                          </tr>
                        </thead>
                        <tbody>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Nose</td>
                            <td align="center" rowspan="1" colspan="1">218<xref ref-type="table-fn" rid="t002fn002"><sup>1</sup></xref></td>
                            <td align="center" rowspan="1" colspan="1">1.5 ± 1.0</td>
                            <td align="center" rowspan="1" colspan="1">0.0–3.8, 1.5 (0.3)</td>
                            <td align="center" rowspan="1" colspan="1">20 (9.2%)</td>
                            <td align="center" rowspan="1" colspan="1">0 (0.0%)</td>
                            <td align="center" rowspan="1" colspan="1">2 (0.9%)</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Throat</td>
                            <td align="center" rowspan="1" colspan="1">218<xref ref-type="table-fn" rid="t002fn002"><sup>1</sup></xref></td>
                            <td align="center" rowspan="1" colspan="1">1.5 ± 1.2</td>
                            <td align="center" rowspan="1" colspan="1">0.0–4.0, 1.3 (0.3)</td>
                            <td align="center" rowspan="1" colspan="1">26 (11.9%)</td>
                            <td align="center" rowspan="1" colspan="1">5 (2.3%)</td>
                            <td align="center" rowspan="1" colspan="1">2 (0.9%)</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Eyes</td>
                            <td align="center" rowspan="1" colspan="1">218<xref ref-type="table-fn" rid="t002fn002"><sup>1</sup></xref></td>
                            <td align="center" rowspan="1" colspan="1">0.9 ± 1.0</td>
                            <td align="center" rowspan="1" colspan="1">0.0–4.0, 0.7 (0.0)</td>
                            <td align="center" rowspan="1" colspan="1">61 (28.0%)</td>
                            <td align="center" rowspan="1" colspan="1">3 (1.4%)</td>
                            <td align="center" rowspan="1" colspan="1">2 (0.9%)</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Chest/<break/>Respiratory</td>
                            <td align="center" rowspan="1" colspan="1">218<xref ref-type="table-fn" rid="t002fn002"><sup>1</sup></xref></td>
                            <td align="center" rowspan="1" colspan="1">1.4 ± 0.8</td>
                            <td align="center" rowspan="1" colspan="1">0.0–3.7, 1.3 (1.3)</td>
                            <td align="center" rowspan="1" colspan="1">9 (4.1%)</td>
                            <td align="center" rowspan="1" colspan="1">0 (0.0%)</td>
                            <td align="center" rowspan="1" colspan="1">2 (0.9%)</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Gastrointestinal</td>
                            <td align="center" rowspan="1" colspan="1">219</td>
                            <td align="center" rowspan="1" colspan="1">0.5 ± 0.7</td>
                            <td align="center" rowspan="1" colspan="1">0.0–3.5, 0.3 (0.0)</td>
                            <td align="center" rowspan="1" colspan="1">103 (47.0%)</td>
                            <td align="center" rowspan="1" colspan="1">0 (0.0%)</td>
                            <td align="center" rowspan="1" colspan="1">1 (0.5%)</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Body/Systemic</td>
                            <td align="center" rowspan="1" colspan="1">219</td>
                            <td align="center" rowspan="1" colspan="1">1.4 ± 0.9</td>
                            <td align="center" rowspan="1" colspan="1">0.0–3.6, 1.3 (0.7)</td>
                            <td align="center" rowspan="1" colspan="1">2 (0.9%)</td>
                            <td align="center" rowspan="1" colspan="1">0 (0.0%)</td>
                            <td align="center" rowspan="1" colspan="1">1 (0.5%)</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Total Score</td>
                            <td align="center" rowspan="1" colspan="1">218<xref ref-type="table-fn" rid="t002fn002"><sup>1</sup></xref></td>
                            <td align="center" rowspan="1" colspan="1">1.3 ± 0.6</td>
                            <td align="center" rowspan="1" colspan="1">0.0–3.1, 1.2 (0.7)</td>
                            <td align="center" rowspan="1" colspan="1">0 (0.0%)</td>
                            <td align="center" rowspan="1" colspan="1">0 (0.0%)</td>
                            <td align="center" rowspan="1" colspan="1">2 (0.9%)</td>
                          </tr>
                        </tbody>
                      </table>
                    </alternatives>
                    <table-wrap-foot>
                      <fn id="t002fn001">
                        <p>Note: higher FLU-PRO scores = more severe symptoms.</p>
                      </fn>
                      <fn id="t002fn002">
                        <p><sup>1</sup> One item was found missing.</p>
                      </fn>
                      <fn id="t002fn003">
                        <p>Abbreviations: SD = Standard Deviation</p>
                      </fn>
                    </table-wrap-foot>
                  </table-wrap>
                </sec>
                <sec id="sec024">
                  <title>Reliability (internal and test-retest)</title>
                  <p>Internal consistency reliability (Cronbach’s alpha) was high for all domains (Nose = 0.80, Throat = 0.84, Eyes = 0.79, Chest/Respiratory = 0.75, Gastrointestinal = 0.72; Body/Systemic = 0.86) and the Total score (0.90).</p>
                  <p>Two-day test-retest reliability during Week 1 are shown in <xref ref-type="table" rid="pone.0194180.t003">Table 3</xref>. Across all two-day assessment periods, FLU-PRO Score ICC and ES estimates were strong. Score reproducibility early in the evaluation (between days 1 and 2) was lowest (Total: 0.64), while reproducibility in the latter days (2–3, 4–5, 5–6) were higher (Total: 0.90, 0.89, 0.88, respectively).</p>
                  <table-wrap id="pone.0194180.t003" orientation="portrait" position="float">
                    <object-id pub-id-type="doi">10.1371/journal.pone.0194180.t003</object-id>
                    <label>Table 3</label>
                    <caption>
                      <title>Two-day test-retest reliability of FLU-PRO scores during Week 1 (Days 1 to Day 7).</title>
                    </caption>
                    <alternatives>
                      <graphic id="pone.0194180.t003g" xlink:href="pone.0194180.t003"/>
                      <table frame="hsides" rules="groups">
                        <colgroup span="1">
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                        </colgroup>
                        <thead>
                          <tr>
                            <th align="left" rowspan="1" colspan="1">FLU-PRO Scores</th>
                            <th align="center" rowspan="1" colspan="1">N<xref ref-type="table-fn" rid="t003fn001"><sup>1</sup></xref></th>
                            <th align="center" rowspan="1" colspan="1">Day X<break/>Mean (SD)</th>
                            <th align="center" rowspan="1" colspan="1">Day Y<break/>Mean (SD)</th>
                            <th align="center" rowspan="1" colspan="1">Mean<break/>Difference (SD)<xref ref-type="table-fn" rid="t003fn002"><sup>2</sup></xref></th>
                            <th align="center" rowspan="1" colspan="1">T<break/>Statistic</th>
                            <th align="center" rowspan="1" colspan="1">p value</th>
                            <th align="center" rowspan="1" colspan="1">Effect<break/>Size</th>
                            <th align="center" rowspan="1" colspan="1">ICC</th>
                          </tr>
                        </thead>
                        <tbody>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">
                              <bold>Day 1 to Day 2</bold>
                            </td>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Nose</td>
                            <td align="center" rowspan="1" colspan="1">50</td>
                            <td align="center" rowspan="1" colspan="1">1.8 (1.0)</td>
                            <td align="center" rowspan="1" colspan="1">1.7 (0.9)</td>
                            <td align="center" rowspan="1" colspan="1">0.1 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">1.05</td>
                            <td align="center" rowspan="1" colspan="1">0.3010</td>
                            <td align="center" rowspan="1" colspan="1">0.09</td>
                            <td align="center" rowspan="1" colspan="1">0.78</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Throat</td>
                            <td align="center" rowspan="1" colspan="1">50</td>
                            <td align="center" rowspan="1" colspan="1">1.7 (1.2)</td>
                            <td align="center" rowspan="1" colspan="1">1.4 (1.1)</td>
                            <td align="center" rowspan="1" colspan="1">0.3 (0.9)</td>
                            <td align="center" rowspan="1" colspan="1">2.26</td>
                            <td align="center" rowspan="1" colspan="1">0.0283</td>
                            <td align="center" rowspan="1" colspan="1">0.26</td>
                            <td align="center" rowspan="1" colspan="1">0.65</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Eyes</td>
                            <td align="center" rowspan="1" colspan="1">50</td>
                            <td align="center" rowspan="1" colspan="1">1.0 (1.0)</td>
                            <td align="center" rowspan="1" colspan="1">1.0 (0.9)</td>
                            <td align="center" rowspan="1" colspan="1">0.1 (0.8)</td>
                            <td align="center" rowspan="1" colspan="1">0.52</td>
                            <td align="center" rowspan="1" colspan="1">0.6041</td>
                            <td align="center" rowspan="1" colspan="1">0.06</td>
                            <td align="center" rowspan="1" colspan="1">0.65</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Chest/Respiratory</td>
                            <td align="center" rowspan="1" colspan="1">50</td>
                            <td align="center" rowspan="1" colspan="1">1.4 (0.8)</td>
                            <td align="center" rowspan="1" colspan="1">1.3 (0.7)</td>
                            <td align="center" rowspan="1" colspan="1">0.0 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">0.51</td>
                            <td align="center" rowspan="1" colspan="1">0.6142</td>
                            <td align="center" rowspan="1" colspan="1">0.05</td>
                            <td align="center" rowspan="1" colspan="1">0.73</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Gastrointestinal</td>
                            <td align="center" rowspan="1" colspan="1">50</td>
                            <td align="center" rowspan="1" colspan="1">0.4 (0.7)</td>
                            <td align="center" rowspan="1" colspan="1">0.3 (0.5)</td>
                            <td align="center" rowspan="1" colspan="1">0.1 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">1.31</td>
                            <td align="center" rowspan="1" colspan="1">0.1965</td>
                            <td align="center" rowspan="1" colspan="1">0.16</td>
                            <td align="center" rowspan="1" colspan="1">0.46</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Body/Systemic</td>
                            <td align="center" rowspan="1" colspan="1">50</td>
                            <td align="center" rowspan="1" colspan="1">1.4 (0.7)</td>
                            <td align="center" rowspan="1" colspan="1">1.2 (0.7)</td>
                            <td align="center" rowspan="1" colspan="1">0.3 (0.7)</td>
                            <td align="center" rowspan="1" colspan="1">2.68</td>
                            <td align="center" rowspan="1" colspan="1">0.0099</td>
                            <td align="center" rowspan="1" colspan="1">0.37</td>
                            <td align="center" rowspan="1" colspan="1">0.50</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Total Score</td>
                            <td align="center" rowspan="1" colspan="1">50</td>
                            <td align="center" rowspan="1" colspan="1">1.3 (0.5)</td>
                            <td align="center" rowspan="1" colspan="1">1.2 (0.5)</td>
                            <td align="center" rowspan="1" colspan="1">0.2 (0.4)</td>
                            <td align="center" rowspan="1" colspan="1">2.56</td>
                            <td align="center" rowspan="1" colspan="1">0.0136</td>
                            <td align="center" rowspan="1" colspan="1">0.29</td>
                            <td align="center" rowspan="1" colspan="1">0.64</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">
                              <bold>Day 2 to Day 3</bold>
                            </td>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Nose</td>
                            <td align="center" rowspan="1" colspan="1">44</td>
                            <td align="center" rowspan="1" colspan="1">1.4 (0.8)</td>
                            <td align="center" rowspan="1" colspan="1">1.4 (0.8)</td>
                            <td align="center" rowspan="1" colspan="1">0.1 (0.4)</td>
                            <td align="center" rowspan="1" colspan="1">0.84</td>
                            <td align="center" rowspan="1" colspan="1">0.4042</td>
                            <td align="center" rowspan="1" colspan="1">0.07</td>
                            <td align="center" rowspan="1" colspan="1">0.86</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Throat</td>
                            <td align="center" rowspan="1" colspan="1">44</td>
                            <td align="center" rowspan="1" colspan="1">1.4 (1.2)</td>
                            <td align="center" rowspan="1" colspan="1">1.2 (0.9)</td>
                            <td align="center" rowspan="1" colspan="1">0.2 (0.8)</td>
                            <td align="center" rowspan="1" colspan="1">1.58</td>
                            <td align="center" rowspan="1" colspan="1">0.1210</td>
                            <td align="center" rowspan="1" colspan="1">0.15</td>
                            <td align="center" rowspan="1" colspan="1">0.74</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Eyes</td>
                            <td align="center" rowspan="1" colspan="1">44</td>
                            <td align="center" rowspan="1" colspan="1">0.8 (0.8)</td>
                            <td align="center" rowspan="1" colspan="1">0.7 (0.9)</td>
                            <td align="center" rowspan="1" colspan="1">0.1 (0.7)</td>
                            <td align="center" rowspan="1" colspan="1">0.84</td>
                            <td align="center" rowspan="1" colspan="1">0.4037</td>
                            <td align="center" rowspan="1" colspan="1">0.11</td>
                            <td align="center" rowspan="1" colspan="1">0.70</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Chest/Respiratory</td>
                            <td align="center" rowspan="1" colspan="1">44</td>
                            <td align="center" rowspan="1" colspan="1">1.4 (0.8)</td>
                            <td align="center" rowspan="1" colspan="1">1.5 (0.8)</td>
                            <td align="center" rowspan="1" colspan="1">-0.1 (0.5)</td>
                            <td align="center" rowspan="1" colspan="1">-1.25</td>
                            <td align="center" rowspan="1" colspan="1">0.2191</td>
                            <td align="center" rowspan="1" colspan="1">0.13</td>
                            <td align="center" rowspan="1" colspan="1">0.78</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Gastrointestinal</td>
                            <td align="center" rowspan="1" colspan="1">45</td>
                            <td align="center" rowspan="1" colspan="1">0.4 (0.7)</td>
                            <td align="center" rowspan="1" colspan="1">0.4 (0.5)</td>
                            <td align="center" rowspan="1" colspan="1">-0.0 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">-0.39</td>
                            <td align="center" rowspan="1" colspan="1">0.6958</td>
                            <td align="center" rowspan="1" colspan="1">0.05</td>
                            <td align="center" rowspan="1" colspan="1">0.55</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Body/Systemic</td>
                            <td align="center" rowspan="1" colspan="1">44</td>
                            <td align="center" rowspan="1" colspan="1">1.1 (0.8)</td>
                            <td align="center" rowspan="1" colspan="1">1.0 (0.7)</td>
                            <td align="center" rowspan="1" colspan="1">0.1 (0.4)</td>
                            <td align="center" rowspan="1" colspan="1">1.97</td>
                            <td align="center" rowspan="1" colspan="1">0.0550</td>
                            <td align="center" rowspan="1" colspan="1">0.16</td>
                            <td align="center" rowspan="1" colspan="1">0.83</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Total Score</td>
                            <td align="center" rowspan="1" colspan="1">44</td>
                            <td align="center" rowspan="1" colspan="1">1.1 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">1.1 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">0.1 (0.3)</td>
                            <td align="center" rowspan="1" colspan="1">1.34</td>
                            <td align="center" rowspan="1" colspan="1">0.1859</td>
                            <td align="center" rowspan="1" colspan="1">0.08</td>
                            <td align="center" rowspan="1" colspan="1">0.90</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">
                              <bold>Day 3 to Day 4</bold>
                            </td>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Nose</td>
                            <td align="center" rowspan="1" colspan="1">41</td>
                            <td align="center" rowspan="1" colspan="1">1.3 (0.9)</td>
                            <td align="center" rowspan="1" colspan="1">1.3 (0.9)</td>
                            <td align="center" rowspan="1" colspan="1">0.0 (0.5)</td>
                            <td align="center" rowspan="1" colspan="1">0.00</td>
                            <td align="center" rowspan="1" colspan="1">1.0000</td>
                            <td align="center" rowspan="1" colspan="1">0.00</td>
                            <td align="center" rowspan="1" colspan="1">0.82</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Throat</td>
                            <td align="center" rowspan="1" colspan="1">41</td>
                            <td align="center" rowspan="1" colspan="1">1.3 (1.1)</td>
                            <td align="center" rowspan="1" colspan="1">1.0 (1.0)</td>
                            <td align="center" rowspan="1" colspan="1">0.3 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">2.52</td>
                            <td align="center" rowspan="1" colspan="1">0.0158</td>
                            <td align="center" rowspan="1" colspan="1">0.23</td>
                            <td align="center" rowspan="1" colspan="1">0.79</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Eyes</td>
                            <td align="center" rowspan="1" colspan="1">41</td>
                            <td align="center" rowspan="1" colspan="1">0.7 (0.9)</td>
                            <td align="center" rowspan="1" colspan="1">0.5 (0.7)</td>
                            <td align="center" rowspan="1" colspan="1">0.2 (0.7)</td>
                            <td align="center" rowspan="1" colspan="1">1.47</td>
                            <td align="center" rowspan="1" colspan="1">0.1485</td>
                            <td align="center" rowspan="1" colspan="1">0.19</td>
                            <td align="center" rowspan="1" colspan="1">0.56</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Chest/Respiratory</td>
                            <td align="center" rowspan="1" colspan="1">41</td>
                            <td align="center" rowspan="1" colspan="1">1.4 (0.8)</td>
                            <td align="center" rowspan="1" colspan="1">1.4 (0.7)</td>
                            <td align="center" rowspan="1" colspan="1">0.0 (0.5)</td>
                            <td align="center" rowspan="1" colspan="1">0.29</td>
                            <td align="center" rowspan="1" colspan="1">0.7727</td>
                            <td align="center" rowspan="1" colspan="1">0.03</td>
                            <td align="center" rowspan="1" colspan="1">0.81</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Gastrointestinal</td>
                            <td align="center" rowspan="1" colspan="1">42</td>
                            <td align="center" rowspan="1" colspan="1">0.2 (0.3)</td>
                            <td align="center" rowspan="1" colspan="1">0.2 (0.4)</td>
                            <td align="center" rowspan="1" colspan="1">0.0 (0.4)</td>
                            <td align="center" rowspan="1" colspan="1">0.38</td>
                            <td align="center" rowspan="1" colspan="1">0.7026</td>
                            <td align="center" rowspan="1" colspan="1">0.07</td>
                            <td align="center" rowspan="1" colspan="1">0.46</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Body/Systemic</td>
                            <td align="center" rowspan="1" colspan="1">42</td>
                            <td align="center" rowspan="1" colspan="1">0.9 (0.8)</td>
                            <td align="center" rowspan="1" colspan="1">0.8 (0.5)</td>
                            <td align="center" rowspan="1" colspan="1">0.1 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">0.79</td>
                            <td align="center" rowspan="1" colspan="1">0.4361</td>
                            <td align="center" rowspan="1" colspan="1">0.09</td>
                            <td align="center" rowspan="1" colspan="1">0.63</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Total Score</td>
                            <td align="center" rowspan="1" colspan="1">41</td>
                            <td align="center" rowspan="1" colspan="1">1.0 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">0.9 (0.5)</td>
                            <td align="center" rowspan="1" colspan="1">0.1 (0.4)</td>
                            <td align="center" rowspan="1" colspan="1">1.19</td>
                            <td align="center" rowspan="1" colspan="1">0.2407</td>
                            <td align="center" rowspan="1" colspan="1">0.12</td>
                            <td align="center" rowspan="1" colspan="1">0.75</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">
                              <bold>Day 4 to Day 5</bold>
                            </td>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Nose</td>
                            <td align="center" rowspan="1" colspan="1">30</td>
                            <td align="center" rowspan="1" colspan="1">0.9 (0.8)</td>
                            <td align="center" rowspan="1" colspan="1">0.8 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">0.1 (0.4)</td>
                            <td align="center" rowspan="1" colspan="1">1.27</td>
                            <td align="center" rowspan="1" colspan="1">0.2156</td>
                            <td align="center" rowspan="1" colspan="1">0.11</td>
                            <td align="center" rowspan="1" colspan="1">0.86</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Throat</td>
                            <td align="center" rowspan="1" colspan="1">30</td>
                            <td align="center" rowspan="1" colspan="1">0.7 (0.9)</td>
                            <td align="center" rowspan="1" colspan="1">0.8 (0.9)</td>
                            <td align="center" rowspan="1" colspan="1">-0.1 (0.7)</td>
                            <td align="center" rowspan="1" colspan="1">-0.44</td>
                            <td align="center" rowspan="1" colspan="1">0.6649</td>
                            <td align="center" rowspan="1" colspan="1">0.06</td>
                            <td align="center" rowspan="1" colspan="1">0.72</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Eyes</td>
                            <td align="center" rowspan="1" colspan="1">30</td>
                            <td align="center" rowspan="1" colspan="1">0.5 (0.8)</td>
                            <td align="center" rowspan="1" colspan="1">0.3 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">0.2 (0.5)</td>
                            <td align="center" rowspan="1" colspan="1">2.34</td>
                            <td align="center" rowspan="1" colspan="1">0.0264</td>
                            <td align="center" rowspan="1" colspan="1">0.25</td>
                            <td align="center" rowspan="1" colspan="1">0.76</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Chest/Respiratory</td>
                            <td align="center" rowspan="1" colspan="1">30</td>
                            <td align="center" rowspan="1" colspan="1">1.1 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">1.0 (0.7)</td>
                            <td align="center" rowspan="1" colspan="1">0.1 (0.3)</td>
                            <td align="center" rowspan="1" colspan="1">1.28</td>
                            <td align="center" rowspan="1" colspan="1">0.2092</td>
                            <td align="center" rowspan="1" colspan="1">0.13</td>
                            <td align="center" rowspan="1" colspan="1">0.86</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Gastrointestinal</td>
                            <td align="center" rowspan="1" colspan="1">31</td>
                            <td align="center" rowspan="1" colspan="1">0.2 (0.4)</td>
                            <td align="center" rowspan="1" colspan="1">0.3 (0.5)</td>
                            <td align="center" rowspan="1" colspan="1">-0.1 (0.3)</td>
                            <td align="center" rowspan="1" colspan="1">-0.94</td>
                            <td align="center" rowspan="1" colspan="1">0.3536</td>
                            <td align="center" rowspan="1" colspan="1">0.15</td>
                            <td align="center" rowspan="1" colspan="1">0.69</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Body/Systemic</td>
                            <td align="center" rowspan="1" colspan="1">31</td>
                            <td align="center" rowspan="1" colspan="1">0.7 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">0.7 (0.7)</td>
                            <td align="center" rowspan="1" colspan="1">-0.0 (0.4)</td>
                            <td align="center" rowspan="1" colspan="1">-0.71</td>
                            <td align="center" rowspan="1" colspan="1">0.4824</td>
                            <td align="center" rowspan="1" colspan="1">0.08</td>
                            <td align="center" rowspan="1" colspan="1">0.83</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Total Score</td>
                            <td align="center" rowspan="1" colspan="1">30</td>
                            <td align="center" rowspan="1" colspan="1">0.7 (0.5)</td>
                            <td align="center" rowspan="1" colspan="1">0.7 (0.5)</td>
                            <td align="center" rowspan="1" colspan="1">0.0 (0.2)</td>
                            <td align="center" rowspan="1" colspan="1">0.42</td>
                            <td align="center" rowspan="1" colspan="1">0.6787</td>
                            <td align="center" rowspan="1" colspan="1">0.04</td>
                            <td align="center" rowspan="1" colspan="1">0.89</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">
                              <bold>Day 5 to Day 6</bold>
                            </td>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Nose</td>
                            <td align="center" rowspan="1" colspan="1">32</td>
                            <td align="center" rowspan="1" colspan="1">0.8 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">0.8 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">-0.0 (0.4)</td>
                            <td align="center" rowspan="1" colspan="1">-0.22</td>
                            <td align="center" rowspan="1" colspan="1">0.8249</td>
                            <td align="center" rowspan="1" colspan="1">0.03</td>
                            <td align="center" rowspan="1" colspan="1">0.76</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Throat</td>
                            <td align="center" rowspan="1" colspan="1">32</td>
                            <td align="center" rowspan="1" colspan="1">0.7 (1.1)</td>
                            <td align="center" rowspan="1" colspan="1">0.7 (1.0)</td>
                            <td align="center" rowspan="1" colspan="1">0.0 (0.2)</td>
                            <td align="center" rowspan="1" colspan="1">1.07</td>
                            <td align="center" rowspan="1" colspan="1">0.2922</td>
                            <td align="center" rowspan="1" colspan="1">0.04</td>
                            <td align="center" rowspan="1" colspan="1">0.98</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Eyes</td>
                            <td align="center" rowspan="1" colspan="1">32</td>
                            <td align="center" rowspan="1" colspan="1">0.4 (0.7)</td>
                            <td align="center" rowspan="1" colspan="1">0.4 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">0.0 (0.5)</td>
                            <td align="center" rowspan="1" colspan="1">0.24</td>
                            <td align="center" rowspan="1" colspan="1">0.8154</td>
                            <td align="center" rowspan="1" colspan="1">0.03</td>
                            <td align="center" rowspan="1" colspan="1">0.71</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Chest/Respiratory</td>
                            <td align="center" rowspan="1" colspan="1">32</td>
                            <td align="center" rowspan="1" colspan="1">1.0 (0.7)</td>
                            <td align="center" rowspan="1" colspan="1">1.0 (0.8)</td>
                            <td align="center" rowspan="1" colspan="1">0.0 (0.5)</td>
                            <td align="center" rowspan="1" colspan="1">0.10</td>
                            <td align="center" rowspan="1" colspan="1">0.9182</td>
                            <td align="center" rowspan="1" colspan="1">0.01</td>
                            <td align="center" rowspan="1" colspan="1">0.79</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Gastrointestinal</td>
                            <td align="center" rowspan="1" colspan="1">32</td>
                            <td align="center" rowspan="1" colspan="1">0.3 (0.4)</td>
                            <td align="center" rowspan="1" colspan="1">0.2 (0.4)</td>
                            <td align="center" rowspan="1" colspan="1">0.0 (0.3)</td>
                            <td align="center" rowspan="1" colspan="1">0.67</td>
                            <td align="center" rowspan="1" colspan="1">0.5089</td>
                            <td align="center" rowspan="1" colspan="1">0.09</td>
                            <td align="center" rowspan="1" colspan="1">0.70</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Body/Systemic</td>
                            <td align="center" rowspan="1" colspan="1">32</td>
                            <td align="center" rowspan="1" colspan="1">0.7 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">0.6 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">0.1 (0.3)</td>
                            <td align="center" rowspan="1" colspan="1">1.99</td>
                            <td align="center" rowspan="1" colspan="1">0.0554</td>
                            <td align="center" rowspan="1" colspan="1">0.17</td>
                            <td align="center" rowspan="1" colspan="1">0.87</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Total Score</td>
                            <td align="center" rowspan="1" colspan="1">32</td>
                            <td align="center" rowspan="1" colspan="1">0.7 (0.5)</td>
                            <td align="center" rowspan="1" colspan="1">0.7 (0.5)</td>
                            <td align="center" rowspan="1" colspan="1">0.0 (0.2)</td>
                            <td align="center" rowspan="1" colspan="1">1.09</td>
                            <td align="center" rowspan="1" colspan="1">0.2861</td>
                            <td align="center" rowspan="1" colspan="1">0.09</td>
                            <td align="center" rowspan="1" colspan="1">0.88</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">
                              <bold>Day 6 to Day 7</bold>
                            </td>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Nose</td>
                            <td align="center" rowspan="1" colspan="1">27</td>
                            <td align="center" rowspan="1" colspan="1">0.8 (0.7)</td>
                            <td align="center" rowspan="1" colspan="1">0.9 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">-0.1 (0.4)</td>
                            <td align="center" rowspan="1" colspan="1">-0.74</td>
                            <td align="center" rowspan="1" colspan="1">0.4637</td>
                            <td align="center" rowspan="1" colspan="1">0.08</td>
                            <td align="center" rowspan="1" colspan="1">0.83</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Throat</td>
                            <td align="center" rowspan="1" colspan="1">27</td>
                            <td align="center" rowspan="1" colspan="1">0.7 (0.9)</td>
                            <td align="center" rowspan="1" colspan="1">0.8 (0.9)</td>
                            <td align="center" rowspan="1" colspan="1">-0.1 (0.5)</td>
                            <td align="center" rowspan="1" colspan="1">-0.66</td>
                            <td align="center" rowspan="1" colspan="1">0.5181</td>
                            <td align="center" rowspan="1" colspan="1">0.07</td>
                            <td align="center" rowspan="1" colspan="1">0.86</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Eyes</td>
                            <td align="center" rowspan="1" colspan="1">27</td>
                            <td align="center" rowspan="1" colspan="1">0.2 (0.3)</td>
                            <td align="center" rowspan="1" colspan="1">0.2 (0.3)</td>
                            <td align="center" rowspan="1" colspan="1">-0.0 (0.2)</td>
                            <td align="center" rowspan="1" colspan="1">-0.27</td>
                            <td align="center" rowspan="1" colspan="1">0.7873</td>
                            <td align="center" rowspan="1" colspan="1">0.04</td>
                            <td align="center" rowspan="1" colspan="1">0.64</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Chest/Respiratory</td>
                            <td align="center" rowspan="1" colspan="1">27</td>
                            <td align="center" rowspan="1" colspan="1">1.0 (0.7)</td>
                            <td align="center" rowspan="1" colspan="1">1.1 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">-0.1 (0.5)</td>
                            <td align="center" rowspan="1" colspan="1">-0.88</td>
                            <td align="center" rowspan="1" colspan="1">0.3885</td>
                            <td align="center" rowspan="1" colspan="1">0.12</td>
                            <td align="center" rowspan="1" colspan="1">0.70</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Gastrointestinal</td>
                            <td align="center" rowspan="1" colspan="1">27</td>
                            <td align="center" rowspan="1" colspan="1">0.1 (0.3)</td>
                            <td align="center" rowspan="1" colspan="1">0.1 (0.2)</td>
                            <td align="center" rowspan="1" colspan="1">-0.0 (0.2)</td>
                            <td align="center" rowspan="1" colspan="1">-0.63</td>
                            <td align="center" rowspan="1" colspan="1">0.5372</td>
                            <td align="center" rowspan="1" colspan="1">0.07</td>
                            <td align="center" rowspan="1" colspan="1">0.82</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Body/Systemic</td>
                            <td align="center" rowspan="1" colspan="1">27</td>
                            <td align="center" rowspan="1" colspan="1">0.5 (0.5)</td>
                            <td align="center" rowspan="1" colspan="1">0.3 (0.3)</td>
                            <td align="center" rowspan="1" colspan="1">0.1 (0.3)</td>
                            <td align="center" rowspan="1" colspan="1">2.26</td>
                            <td align="center" rowspan="1" colspan="1">0.0325</td>
                            <td align="center" rowspan="1" colspan="1">0.27</td>
                            <td align="center" rowspan="1" colspan="1">0.73</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Total Score</td>
                            <td align="center" rowspan="1" colspan="1">27</td>
                            <td align="center" rowspan="1" colspan="1">0.6 (0.4)</td>
                            <td align="center" rowspan="1" colspan="1">0.6 (0.3)</td>
                            <td align="center" rowspan="1" colspan="1">0.0 (0.2)</td>
                            <td align="center" rowspan="1" colspan="1">0.24</td>
                            <td align="center" rowspan="1" colspan="1">0.8106</td>
                            <td align="center" rowspan="1" colspan="1">0.02</td>
                            <td align="center" rowspan="1" colspan="1">0.85</td>
                          </tr>
                        </tbody>
                      </table>
                    </alternatives>
                    <table-wrap-foot>
                      <fn id="t003fn001">
                        <p><sup>1</sup>Number of study participants with no change in flu symptom at day Y. Stable subjects were defined as those with “no change” on the Patient Global Rating of Change in Flu Severity using two consecutive days.</p>
                      </fn>
                      <fn id="t003fn002">
                        <p><sup>2</sup>Mean difference = average Day X FLU-PRO score average Day Y FLU-PRO score (ex. Day 1 score Day 2 score); p value from paired t-test.</p>
                      </fn>
                    </table-wrap-foot>
                  </table-wrap>
                </sec>
                <sec id="sec025">
                  <title>Construct validity</title>
                  <p>As shown in <xref ref-type="table" rid="pone.0194180.t004">Table 4</xref>, at day 1 the strongest associations were observed between FLU-PRO domain and Total scores and the Patient Global Rating of Flu Severity (r<sub>s</sub> = 0.31–0.68, p&lt;0.0001), except Gastrointestinal (r<sub>s</sub> = 0.19, p&lt;0.05). Moderate to high correlations were also found between FLU-PRO scores and the Patient Global Rating of Physical Health for all scores (r<sub>s</sub> = -0.30–-0.49) except Gastrointestinal (r<sub>s</sub> = -0.21), Nose, and Eyes (both r<sub>s</sub> = -0.28). Only associations between the Patient Global Assessment of Interference in Daily Activities and the Total score (r<sub>s</sub> = 0.36, p&lt;0.0001) and Body/Systemic domain score (r<sub>s</sub> = 0.40, p&lt;0.0001) were moderate to strong.</p>
                  <table-wrap id="pone.0194180.t004" orientation="portrait" position="float">
                    <object-id pub-id-type="doi">10.1371/journal.pone.0194180.t004</object-id>
                    <label>Table 4</label>
                    <caption>
                      <title>Construct validity: FLU-PRO scale correlations with other PRO measures at Day 1.</title>
                    </caption>
                    <alternatives>
                      <graphic id="pone.0194180.t004g" xlink:href="pone.0194180.t004"/>
                      <table frame="hsides" rules="groups">
                        <colgroup span="1">
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                        </colgroup>
                        <thead>
                          <tr>
                            <th align="left" rowspan="1" colspan="1"/>
                            <th align="center" colspan="7" rowspan="1">Domains and Total Score, r (p-value)<xref ref-type="table-fn" rid="t004fn001"><sup>1</sup></xref></th>
                          </tr>
                          <tr>
                            <th align="left" rowspan="1" colspan="1">Day 1</th>
                            <th align="center" rowspan="1" colspan="1">Nose</th>
                            <th align="center" rowspan="1" colspan="1">Throat</th>
                            <th align="center" rowspan="1" colspan="1">Eyes</th>
                            <th align="center" rowspan="1" colspan="1">Chest/<break/>Respiratory</th>
                            <th align="center" rowspan="1" colspan="1">Gastrointestinal</th>
                            <th align="center" rowspan="1" colspan="1">Body/<break/>Systemic</th>
                            <th align="center" rowspan="1" colspan="1">Total<break/>Score</th>
                          </tr>
                        </thead>
                        <tbody>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Patient Global Rating of Flu Severity<xref ref-type="table-fn" rid="t004fn002"><sup><bold>2</bold></sup></xref></td>
                            <td align="center" rowspan="1" colspan="1">0.44***</td>
                            <td align="center" rowspan="1" colspan="1">0.47***</td>
                            <td align="center" rowspan="1" colspan="1">0.48***</td>
                            <td align="center" rowspan="1" colspan="1">0.31***</td>
                            <td align="center" rowspan="1" colspan="1">0.19*</td>
                            <td align="center" rowspan="1" colspan="1">0.63***</td>
                            <td align="center" rowspan="1" colspan="1">0.68***</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Patient Global Rating of Physical Health<xref ref-type="table-fn" rid="t004fn003"><sup><bold>3</bold></sup></xref></td>
                            <td align="center" rowspan="1" colspan="1">-0.28***</td>
                            <td align="center" rowspan="1" colspan="1">-0.31***</td>
                            <td align="center" rowspan="1" colspan="1">-0.28***</td>
                            <td align="center" rowspan="1" colspan="1">-0.30***</td>
                            <td align="center" rowspan="1" colspan="1">-0.21*</td>
                            <td align="center" rowspan="1" colspan="1">-0.43***</td>
                            <td align="center" rowspan="1" colspan="1">-0.49***</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Patient Global Assessment of Interference in Daily Activities<xref ref-type="table-fn" rid="t004fn004"><sup><bold>4</bold></sup></xref></td>
                            <td align="center" rowspan="1" colspan="1">0.07</td>
                            <td align="center" rowspan="1" colspan="1">0.11</td>
                            <td align="center" rowspan="1" colspan="1">0.17*</td>
                            <td align="center" rowspan="1" colspan="1">0.27***</td>
                            <td align="center" rowspan="1" colspan="1">0.19*</td>
                            <td align="center" rowspan="1" colspan="1">0.40***</td>
                            <td align="center" rowspan="1" colspan="1">0.36***</td>
                          </tr>
                        </tbody>
                      </table>
                    </alternatives>
                    <table-wrap-foot>
                      <fn id="t004fn001">
                        <p><sup>1</sup>Spearman correlation coefficients: ***p&lt;0.0001, *p&lt;0.05</p>
                      </fn>
                      <fn id="t004fn002">
                        <p><sup>2</sup>Greater values indicate greater disease severity</p>
                      </fn>
                      <fn id="t004fn003">
                        <p><sup>3</sup>Greater values indicate better patient health</p>
                      </fn>
                      <fn id="t004fn004">
                        <p><sup>4</sup>Greater values indicate greater interference with daily activities</p>
                      </fn>
                    </table-wrap-foot>
                  </table-wrap>
                </sec>
                <sec id="sec026">
                  <title>Known-groups validity</title>
                  <p>Significant differences in FLU-PRO total scores were found across patient groups according to the patient global symptom severity rating (F = 81.7, p&lt;0.001). Mean [SD] scores were lowest in the No/Mild Symptoms group (0.81 [0.45]), followed by the Moderate (1.28 [0.48]) and Severe/Very Severe groups (1.84 [0.49]). All pairwise comparisons using Scheffe’s test were statistically significant (p&lt;0.001). A similar pattern of mean values was demonstrated for all FLU-PRO domain scores. Further, pairwise comparisons for each domain score showed a similar pattern to the Total score, with the exception of the No/Mild symptoms versus Moderate for the Chest/Respiratory and Gastrointestinal domains, and Moderate versus Severe/Very Severe for the Nose domain, which were in the correct direction but nonsignificant (p&gt;0.05) (<xref ref-type="table" rid="pone.0194180.t005">Table 5</xref>).</p>
                  <table-wrap id="pone.0194180.t005" orientation="portrait" position="float">
                    <object-id pub-id-type="doi">10.1371/journal.pone.0194180.t005</object-id>
                    <label>Table 5</label>
                    <caption>
                      <title>Known-groups validity: FLU-PRO scores by patient global rating of disease severity, Day 1.</title>
                    </caption>
                    <alternatives>
                      <graphic id="pone.0194180.t005g" xlink:href="pone.0194180.t005"/>
                      <table frame="hsides" rules="groups">
                        <colgroup span="1">
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                        </colgroup>
                        <thead>
                          <tr>
                            <th align="left" rowspan="1" colspan="1"/>
                            <th align="center" colspan="3" rowspan="1">Patient Global Rating of Flu Severity</th>
                            <th align="center" colspan="2" rowspan="1"/>
                            <th align="center" rowspan="1" colspan="1"/>
                            <th align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <th align="left" rowspan="1" colspan="1"/>
                            <th align="center" rowspan="1" colspan="1">No/Mild</th>
                            <th align="center" rowspan="1" colspan="1"/>
                            <th align="center" rowspan="1" colspan="1">Severe and</th>
                            <th align="center" colspan="2" rowspan="1"/>
                            <th align="center" rowspan="1" colspan="1"/>
                            <th align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <th align="left" rowspan="1" colspan="1"/>
                            <th align="center" rowspan="1" colspan="1">Symptoms (N = 81)</th>
                            <th align="center" rowspan="1" colspan="1">Moderate (N = 77)</th>
                            <th align="center" rowspan="1" colspan="1">Very Severe (N = 60)</th>
                            <th align="center" colspan="2" rowspan="1"/>
                            <th align="center" rowspan="1" colspan="1"/>
                            <th align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <th align="left" rowspan="1" colspan="1">Scale</th>
                            <th align="center" rowspan="1" colspan="1">Mean (SD)</th>
                            <th align="center" rowspan="1" colspan="1">Mean (SD)</th>
                            <th align="center" rowspan="1" colspan="1">Mean <break/>(SD)</th>
                            <th align="center" rowspan="1" colspan="1">F Value<break/>(p-value)<xref ref-type="table-fn" rid="t005fn001"><sup>1</sup></xref></th>
                            <th align="center" rowspan="1" colspan="1">Pairwise<break/>Comparisons: No/Mild vs Moderate <break/>(p-value)</th>
                            <th align="center" rowspan="1" colspan="1">Pairwise<break/>Comparisons: No/Mild vs Severe/Very Severe (p-value)</th>
                            <th align="center" rowspan="1" colspan="1">Pairwise<break/>Comparisons: Moderate vs Severe/Very Severe (p-value)</th>
                          </tr>
                        </thead>
                        <tbody>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Nose</td>
                            <td align="center" rowspan="1" colspan="1">0.89 (0.74)</td>
                            <td align="center" rowspan="1" colspan="1">1.65 (0.98)</td>
                            <td align="center" rowspan="1" colspan="1">2.00 (1.09)</td>
                            <td align="center" rowspan="1" colspan="1">26.9***</td>
                            <td align="center" rowspan="1" colspan="1">p&lt;0.001</td>
                            <td align="center" rowspan="1" colspan="1">p&lt;0.001</td>
                            <td align="center" rowspan="1" colspan="1">NS</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Throat</td>
                            <td align="center" rowspan="1" colspan="1">0.97 (0.98)</td>
                            <td align="center" rowspan="1" colspan="1">1.48 (0.99)</td>
                            <td align="center" rowspan="1" colspan="1">2.41 (1.21)</td>
                            <td align="center" rowspan="1" colspan="1">32.4***</td>
                            <td align="center" rowspan="1" colspan="1">p&lt;0.05</td>
                            <td align="center" rowspan="1" colspan="1">p&lt;0.001</td>
                            <td align="center" rowspan="1" colspan="1">p&lt;0.001</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Eyes</td>
                            <td align="center" rowspan="1" colspan="1">0.37 (0.52)</td>
                            <td align="center" rowspan="1" colspan="1">1.04 (0.84)</td>
                            <td align="center" rowspan="1" colspan="1">1.48 (1.18)</td>
                            <td align="center" rowspan="1" colspan="1">30.7***</td>
                            <td align="center" rowspan="1" colspan="1">p&lt;0.001</td>
                            <td align="center" rowspan="1" colspan="1">p&lt;0.001</td>
                            <td align="center" rowspan="1" colspan="1">p&lt;0.05</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Chest/Respiratory</td>
                            <td align="center" rowspan="1" colspan="1">1.14 (0.73)</td>
                            <td align="center" rowspan="1" colspan="1">1.42 (0.69)</td>
                            <td align="center" rowspan="1" colspan="1">1.79 (0.93)</td>
                            <td align="center" rowspan="1" colspan="1">12.0***</td>
                            <td align="center" rowspan="1" colspan="1">NS</td>
                            <td align="center" rowspan="1" colspan="1">p&lt;0.001</td>
                            <td align="center" rowspan="1" colspan="1">p&lt;0.05</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Gastrointestinal</td>
                            <td align="center" rowspan="1" colspan="1">0.32 (0.61)</td>
                            <td align="center" rowspan="1" colspan="1">0.38 (0.53)</td>
                            <td align="center" rowspan="1" colspan="1">0.72 (0.89)</td>
                            <td align="center" rowspan="1" colspan="1">6.9**</td>
                            <td align="center" rowspan="1" colspan="1">NS</td>
                            <td align="center" rowspan="1" colspan="1">p&lt;0.01</td>
                            <td align="center" rowspan="1" colspan="1">p&lt;0.05</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Body/Systemic</td>
                            <td align="center" rowspan="1" colspan="1">0.83 (0.65)</td>
                            <td align="center" rowspan="1" colspan="1">1.40 (0.71)</td>
                            <td align="center" rowspan="1" colspan="1">2.15 (0.75)</td>
                            <td align="center" rowspan="1" colspan="1">62.2***</td>
                            <td align="center" rowspan="1" colspan="1">p&lt;0.001</td>
                            <td align="center" rowspan="1" colspan="1">p&lt;0.001</td>
                            <td align="center" rowspan="1" colspan="1">p&lt;0.001</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">Total Score</td>
                            <td align="center" rowspan="1" colspan="1">0.81 (0.45)</td>
                            <td align="center" rowspan="1" colspan="1">1.28 (0.48)</td>
                            <td align="center" rowspan="1" colspan="1">1.84 (0.49)</td>
                            <td align="center" rowspan="1" colspan="1">81.7***</td>
                            <td align="center" rowspan="1" colspan="1">p&lt;0.001</td>
                            <td align="center" rowspan="1" colspan="1">p&lt;0.001</td>
                            <td align="center" rowspan="1" colspan="1">p&lt;0.001</td>
                          </tr>
                        </tbody>
                      </table>
                    </alternatives>
                    <table-wrap-foot>
                      <fn id="t005fn001">
                        <p><sup>1</sup>p values are: **&lt;0.01, ***&lt;0.001.</p>
                      </fn>
                      <fn id="t005fn002">
                        <p>Abbreviations: SD = Standard Deviation; NS = Non-significant</p>
                      </fn>
                    </table-wrap-foot>
                  </table-wrap>
                </sec>
                <sec id="sec027">
                  <title>Responsiveness</title>
                  <p>Change in FLU-PRO total and domain scores across time are shown in <xref ref-type="fig" rid="pone.0194180.g001">Fig 1</xref>, demonstrating a reduction in mean scores across days 1–14. In support of responsiveness, mean total and domain change scores were significantly greater for patients reporting a return to usual health (responders) by day 7, compared to those who did not, with the exception of the Eyes and Gastrointestinal domains (<xref ref-type="table" rid="pone.0194180.t006">Table 6</xref>). Using patient’s report of return to usual activities as an anchor for responsiveness, mean Total and Body/Systemic change scores were significantly greater for responders, while all other comparisons failed to reach statistical significance (p&gt;0.05).</p>
                  <fig id="pone.0194180.g001" orientation="portrait" position="float">
                    <object-id pub-id-type="doi">10.1371/journal.pone.0194180.g001</object-id>
                    <label>Fig 1</label>
                    <caption>
                      <title>FLU-PRO domain and total score by diary days 1 to 14: Influenza-Negative Patients.</title>
                    </caption>
                    <graphic xlink:href="pone.0194180.g001"/>
                  </fig>
                  <table-wrap id="pone.0194180.t006" orientation="portrait" position="float">
                    <object-id pub-id-type="doi">10.1371/journal.pone.0194180.t006</object-id>
                    <label>Table 6</label>
                    <caption>
                      <title>Responsiveness of FLU-PRO by patient return to usual health (N = 169)<xref ref-type="table-fn" rid="t006fn001"><sup>1</sup></xref> and usual activities (N = 117)<xref ref-type="table-fn" rid="t006fn002"><sup>2</sup></xref>, Day 1 to Day 7.</title>
                    </caption>
                    <alternatives>
                      <graphic id="pone.0194180.t006g" xlink:href="pone.0194180.t006"/>
                      <table frame="hsides" rules="groups">
                        <colgroup span="1">
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                        </colgroup>
                        <thead>
                          <tr>
                            <th align="left" rowspan="1" colspan="1"/>
                            <th align="center" colspan="3" rowspan="1">Responders<xref ref-type="table-fn" rid="t006fn003"><sup>3</sup></xref></th>
                            <th align="center" colspan="3" rowspan="1">Non-Responders</th>
                            <th align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <th align="left" rowspan="1" colspan="1">Scale</th>
                            <th align="center" rowspan="1" colspan="1">Day 1 Mean<break/>(SD)</th>
                            <th align="center" rowspan="1" colspan="1">Day 7 Mean<break/>(SD)</th>
                            <th align="center" rowspan="1" colspan="1">Change Score<break/>LSMean<break/>(SDerr)</th>
                            <th align="center" rowspan="1" colspan="1">Day 1 Mean<break/>(SD)</th>
                            <th align="center" rowspan="1" colspan="1">Day 7 Mean<break/>(SD)</th>
                            <th align="center" rowspan="1" colspan="1">Change Score<break/>LSMean<break/>(SDerr)</th>
                            <th align="center" rowspan="1" colspan="1">p-value<xref ref-type="table-fn" rid="t006fn004"><sup>4</sup></xref></th>
                          </tr>
                        </thead>
                        <tbody>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">
                              <bold>Nose</bold>
                            </td>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Usual Health</td>
                            <td align="center" rowspan="1" colspan="1">1.5 (1.0)</td>
                            <td align="center" rowspan="1" colspan="1">0.5 (0.5)</td>
                            <td align="center" rowspan="1" colspan="1">1.0 (0.1)</td>
                            <td align="center" rowspan="1" colspan="1">1.4 (1.0)</td>
                            <td align="center" rowspan="1" colspan="1">0.8 (0.7)</td>
                            <td align="center" rowspan="1" colspan="1">0.7 (0.1)</td>
                            <td align="center" rowspan="1" colspan="1">0.0003</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Usual Activities</td>
                            <td align="center" rowspan="1" colspan="1">1.6 (1.1)</td>
                            <td align="center" rowspan="1" colspan="1">0.7 (0.7)</td>
                            <td align="center" rowspan="1" colspan="1">0.7 (0.1)</td>
                            <td align="center" rowspan="1" colspan="1">0.9 (0.8)</td>
                            <td align="center" rowspan="1" colspan="1">0.5 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">0.7 (0.1)</td>
                            <td align="center" rowspan="1" colspan="1">0.8751</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">
                              <bold>Throat</bold>
                            </td>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Usual Health</td>
                            <td align="center" rowspan="1" colspan="1">1.5 (1.1)</td>
                            <td align="center" rowspan="1" colspan="1">0.3 (0.5)</td>
                            <td align="center" rowspan="1" colspan="1">1.2 (0.1)</td>
                            <td align="center" rowspan="1" colspan="1">1.7 (1.3)</td>
                            <td align="center" rowspan="1" colspan="1">0.7 (0.8)</td>
                            <td align="center" rowspan="1" colspan="1">0.9 (0.1)</td>
                            <td align="center" rowspan="1" colspan="1">0.0029</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Usual Activities</td>
                            <td align="center" rowspan="1" colspan="1">1.8 (1.2)</td>
                            <td align="center" rowspan="1" colspan="1">0.5 (0.7)</td>
                            <td align="center" rowspan="1" colspan="1">1.1 (0.1)</td>
                            <td align="center" rowspan="1" colspan="1">1.1 (1.2)</td>
                            <td align="center" rowspan="1" colspan="1">0.5 (0.9)</td>
                            <td align="center" rowspan="1" colspan="1">0.9 (0.1)</td>
                            <td align="center" rowspan="1" colspan="1">0.1351</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">
                              <bold>Eyes</bold>
                            </td>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Usual Health</td>
                            <td align="center" rowspan="1" colspan="1">0.9 (1.1)</td>
                            <td align="center" rowspan="1" colspan="1">0.1 (0.4)</td>
                            <td align="center" rowspan="1" colspan="1">0.7 (0.1)</td>
                            <td align="center" rowspan="1" colspan="1">0.9 (0.9)</td>
                            <td align="center" rowspan="1" colspan="1">0.3 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">0.6 (0.0)</td>
                            <td align="center" rowspan="1" colspan="1">0.1202</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Usual Activities</td>
                            <td align="center" rowspan="1" colspan="1">1.0 (1.1)</td>
                            <td align="center" rowspan="1" colspan="1">0.2 (0.5)</td>
                            <td align="center" rowspan="1" colspan="1">0.7 (0.1)</td>
                            <td align="center" rowspan="1" colspan="1">0.6 (0.9)</td>
                            <td align="center" rowspan="1" colspan="1">0.2 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">0.6 (0.1)</td>
                            <td align="center" rowspan="1" colspan="1">0.0919</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">
                              <bold>Chest/Respiratory</bold>
                            </td>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Usual Health</td>
                            <td align="center" rowspan="1" colspan="1">1.3 (0.7)</td>
                            <td align="center" rowspan="1" colspan="1">0.5 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">0.9 (0.1)</td>
                            <td align="center" rowspan="1" colspan="1">1.5 (0.8)</td>
                            <td align="center" rowspan="1" colspan="1">1.0 (0.7)</td>
                            <td align="center" rowspan="1" colspan="1">0.5 (0.1)</td>
                            <td align="center" rowspan="1" colspan="1">&lt; .0001</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Usual Activities</td>
                            <td align="center" rowspan="1" colspan="1">1.4 (0.8)</td>
                            <td align="center" rowspan="1" colspan="1">0.8 (0.7)</td>
                            <td align="center" rowspan="1" colspan="1">0.7 (0.1)</td>
                            <td align="center" rowspan="1" colspan="1">1.6 (0.8)</td>
                            <td align="center" rowspan="1" colspan="1">0.8 (0.8)</td>
                            <td align="center" rowspan="1" colspan="1">0.7 (0.1)</td>
                            <td align="center" rowspan="1" colspan="1">0.6139</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">
                              <bold>Gastrointestinal</bold>
                            </td>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Usual Health</td>
                            <td align="center" rowspan="1" colspan="1">0.4 (0.7)</td>
                            <td align="center" rowspan="1" colspan="1">0.1 (0.3)</td>
                            <td align="center" rowspan="1" colspan="1">0.3 (0.0)</td>
                            <td align="center" rowspan="1" colspan="1">0.4 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">0.2 (0.4)</td>
                            <td align="center" rowspan="1" colspan="1">0.2 (0.0)</td>
                            <td align="center" rowspan="1" colspan="1">0.0585</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Usual Activities</td>
                            <td align="center" rowspan="1" colspan="1">0.4 (0.7)</td>
                            <td align="center" rowspan="1" colspan="1">0.1 (0.2)</td>
                            <td align="center" rowspan="1" colspan="1">0.4 (0.0)</td>
                            <td align="center" rowspan="1" colspan="1">0.4 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">0.2 (0.5)</td>
                            <td align="center" rowspan="1" colspan="1">0.3 (0.0)</td>
                            <td align="center" rowspan="1" colspan="1">0.0777</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">
                              <bold>Body/Systemic</bold>
                            </td>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Usual Health</td>
                            <td align="center" rowspan="1" colspan="1">1.3 (0.9)</td>
                            <td align="center" rowspan="1" colspan="1">0.2 (0.3)</td>
                            <td align="center" rowspan="1" colspan="1">1.2 (0.1)</td>
                            <td align="center" rowspan="1" colspan="1">1.4 (0.9)</td>
                            <td align="center" rowspan="1" colspan="1">0.5 (0.5)</td>
                            <td align="center" rowspan="1" colspan="1">0.9 (0.0)</td>
                            <td align="center" rowspan="1" colspan="1">&lt; .0001</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Usual Activities</td>
                            <td align="center" rowspan="1" colspan="1">1.6 (0.9)</td>
                            <td align="center" rowspan="1" colspan="1">0.3 (0.4)</td>
                            <td align="center" rowspan="1" colspan="1">1.2 (0.0)</td>
                            <td align="center" rowspan="1" colspan="1">1.1 (0.9)</td>
                            <td align="center" rowspan="1" colspan="1">0.5 (0.5)</td>
                            <td align="center" rowspan="1" colspan="1">0.9 (0.1)</td>
                            <td align="center" rowspan="1" colspan="1">0.0004</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">
                              <bold>Total Score</bold>
                            </td>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Usual Health</td>
                            <td align="center" rowspan="1" colspan="1">1.2 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">0.3 (0.3)</td>
                            <td align="center" rowspan="1" colspan="1">0.9 (0.0)</td>
                            <td align="center" rowspan="1" colspan="1">1.3 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">0.6 (0.5)</td>
                            <td align="center" rowspan="1" colspan="1">0.7 (0.0)</td>
                            <td align="center" rowspan="1" colspan="1">&lt; .0001</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Usual Activities</td>
                            <td align="center" rowspan="1" colspan="1">1.4 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">0.5 (0.4)</td>
                            <td align="center" rowspan="1" colspan="1">0.9 (0.0)</td>
                            <td align="center" rowspan="1" colspan="1">1.1 (0.6)</td>
                            <td align="center" rowspan="1" colspan="1">0.5 (0.5)</td>
                            <td align="center" rowspan="1" colspan="1">0.7 (0.1)</td>
                            <td align="center" rowspan="1" colspan="1">0.0064</td>
                          </tr>
                        </tbody>
                      </table>
                    </alternatives>
                    <table-wrap-foot>
                      <fn id="t006fn001">
                        <p><sup>1</sup>Responders: N = 64; Non-responders: N = 105</p>
                      </fn>
                      <fn id="t006fn002">
                        <p><sup>2</sup>Responders: N = 69; Non-responders: N = 48</p>
                      </fn>
                      <fn id="t006fn003">
                        <p><sup>3</sup>Responders are defined as patients responding that they have returned to their usual health or usual activities at Day 7.</p>
                      </fn>
                      <fn id="t006fn004">
                        <p><sup>4</sup>Analysis of covariance was used to compare changes in FLU-PRO scores at day 7 in responders and non-responders, adjusting for day 1 scores.</p>
                      </fn>
                    </table-wrap-foot>
                  </table-wrap>
                </sec>
              </sec>
              <sec id="sec028">
                <title>Exploratory comparisons between influenza positive and ILI patient scores</title>
                <p>Patients with confirmed influenza had statistically significantly greater symptom severity at day 1 compared to patients with ILI, including FLU-PRO Total (p&lt;0.0001), Nose (p&lt;0.05), Chest/Respiratory (p&lt;0.0001), Gastrointestinal (p&lt;0.01), and Body/Systemic scores (p&lt;0.0001) (Table L and Figure C in <xref ref-type="supplementary-material" rid="pone.0194180.s001">S1 File</xref>). The Throat and Eyes domains were not significantly different between groups (p&gt;0.05). Scores were also examined by hospitalization status. In those not hospitalized, ILI patients reported significantly greater Throat scores than the influenza positive patients (p = 0.0174); while the influenza positive patients reported significantly greater Chest/Respiratory, Body/Systemic, and Total scores compared to ILI patients (p&lt;0.05) (Figure D in <xref ref-type="supplementary-material" rid="pone.0194180.s001">S1 File</xref>). Among hospitalized patients, those with confirmed influenza reported significantly greater Nose, Gastrointestinal, Body/Systemic, and Total score compared to ILI patients (all p&lt;0.05) (Figure E in <xref ref-type="supplementary-material" rid="pone.0194180.s001">S1 File</xref>). In addition, for both patients with confirmed influenza and ILI, the Patient Global Rating of Flu Severity scores decreased from day 1 to 14, as was seen with FLU-PRO total and domain scores (Figure F in <xref ref-type="supplementary-material" rid="pone.0194180.s001">S1 File</xref>).</p>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec029">
              <title>Discussion</title>
              <p>The objective of this study was to assess the performance properties of the FLU-PRO in patients seen in the clinic with ILI and testing negative for the influenza virus. For FDA qualification purposes, the FLU-PRO was developed and tested in patients with acute, laboratory-confirmed influenza, with scores exhibiting sound measurement properties in the sample overall and stratified by hospitalization status. This current study tested the properties of FLU-PRO scores in hospitalized and non-hospitalized patients with ILI. If the instrument performs well, this would facilitate its use in population-level epidemiologic studies and natural history studies, where laboratory diagnosis of influenza is not always sought or confirmed, and in studies of patients with influenza-like symptoms but infected with viruses or pathogens other than influenza.</p>
              <p>Results of this study indicate FLU-PRO scores are reliable and reproducible, demonstrate construct and known-groups validity, and are responsive to change in subjects with ILI. Internal consistency levels were high for each of the domains and the total score, and 2-day test-retest reliability levels during the first seven days following enrollment were generally moderate to strong. The relatively low test-retest reliability of the Gastrointestinal domain is due, in part, to the low symptom prevalence and constrained variance. Further evaluation in patients with influenza strains or pathogens characterized by greater incidence of gastrointestinal distress should be performed, as gastrointestinal symptoms may occur in up to 40% of patients with influenza [<xref rid="pone.0194180.ref014" ref-type="bibr">14</xref>]. It was interesting to note that score reproducibility was lower during the first 2 assessment days in “stable” patients (those reporting “no change” in their symptoms). This may be a reflection of the relative nature of “no change” during recovery from an acute illness, an interpretation that could be explored qualitatively.</p>
              <p>As hypothesized and in support of construct validity, FLU-PRO scores were significantly related to patient global ratings of influenza severity and global health, with patterns and values similar to those found in the influenza positive sample. Weaker associations were observed with the patient global rating of interference with activities, as patients may return to usual activities before total improvement/resolution of symptoms. The data similarly supported known-groups validity as FLU-PRO scores were lowest in patients rating their symptoms as the mildest, and increased with increasing patient-reported symptom severity. It was interesting to note that eye, nose, and throat symptoms were more strongly related to flu severity than respiratory symptoms in milder cases (defined by patient global assessment), with respiratory symptoms sensitive to differences in the more severe cases. These results suggest the non-respiratory domains may be particularly useful in studies of patients with milder influenza-like illness and to capture the full range of symptom severity. The low prevalence of gastrointestinal symptoms (relatively high percentage of participants reporting no gastrointestinal symptoms) would make it more difficult to show significant differences by patient global ratings of influenza severity. Further study in patients with strains or pathogens characterized by gastrointestinal effects are needed.</p>
              <p>When responders were defined by reports of return to usual health, the FLU-PRO demonstrated responsiveness to change from day 1–7. Similar to results observed in the influenza positive sample, FLU-PRO total and domain scores, except for Eyes and Gastrointestinal, were responsive to change in the ILI group when return to health was used to define response. Using return to usual activities as an anchor, responsiveness in ILI patients was shown in the total and Body/Systemic domain scores.</p>
              <p>Comparing current study findings in patients with ILI to influenza-positive patients in the original validation study sample [<xref rid="pone.0194180.ref010" ref-type="bibr">10</xref>], the FLU-PRO performed similarly in both patient groups. FLU-PRO domain and total score reliability and reproducibility was supported, with similar coefficient profiles across domains. Additionally, there were moderate to strong correlations between FLU-PRO domain and total scores and Patient Global Rating of Flu Severity, Correlations with interference with daily activities were stronger in the laboratory-confirmed influenza patient population.</p>
              <p>Results of this study show the utility of the multi-domain profile scores provided by the FLU-PRO. Unlike other measures that assess 1 or 2 dimensions of influenza symptom severity for use in either adults or children [<xref rid="pone.0194180.ref007" ref-type="bibr">7</xref>,<xref rid="pone.0194180.ref008" ref-type="bibr">8</xref>], the FLU-PRO is a comprehensive, multi-dimensional measure with content intended for use across a wide age spectrum [<xref rid="pone.0194180.ref009" ref-type="bibr">9</xref>]. Its structure yields a total score, representing symptom severity overall to facilitate hypothesis testing, and separate assessments of 6 different bodily systems that may be differentially affected by the virus and/or treatment. For example, the FLUiiQ assesses two domains: respiratory and systemic domains, with cough, sore throat, and nasal congestion symptoms captured within a single domain [<xref rid="pone.0194180.ref007" ref-type="bibr">7</xref>]. However, the ILI experienced by the patients in the current study was characterized by sore throat, with less severe respiratory and systemic symptoms than observed in patients testing positive for the influenza virus. The detailed body system profile can capture these symptoms which patients stated were important to them [<xref rid="pone.0194180.ref009" ref-type="bibr">9</xref>], and also provide information on where treatment is and is not providing symptomatic relief.</p>
              <p>Gastrointestinal symptoms were experienced by less than 25% of the sample, indicating these symptoms were not prevalent in the year of this study but have been observed in a greater proportion of patients in other years with different circulating viral strains. Although this is technically a floor effect, the results provided quantitative information on the prevalence of gastrointestinal symptoms in this sample [<xref rid="pone.0194180.ref014" ref-type="bibr">14</xref>]. The Gastrointestinal domain should be retained, to assure comprehensive symptom assessment across viral strains or pathogens.</p>
              <p>While the findings of the current study suggest FLU-PRO scores are reliable, valid, and responsive in this expanded target population, the study had several limitations. First, although patients were tested for influenza using RIDTs, the sensitivity and sensitivity of these tests for detecting influenza A or B can vary, and can differ pending the strain of influenza circulating during any given year [<xref rid="pone.0194180.ref015" ref-type="bibr">15</xref>,<xref rid="pone.0194180.ref016" ref-type="bibr">16</xref>]. Thus, it is likely that some ILI patients in this study were infected with influenza A or B. Testing for viruses other than influenza was not available at most sites, precluding analyses by viral etiology. The FLU-PRO performance can be evaluated in various specific viral infections in future studies. It is important to note that the purpose of the FLU-PRO is not to diagnose or to differentiate influenza types. Rather, it is to quantify the presence and severity of symptoms that are characteristic of various influenza and other respiratory viruses. The FLU-PRO performed well in those testing positive for influenza [<xref rid="pone.0194180.ref010" ref-type="bibr">10</xref>], the primary analyses of the study, with the current study suggesting the performance properties were comparable in patients presenting to the clinic with a similar set of symptoms but testing negative for influenza using the RIDT. Second, although hospitalized patients were included in the analytic sample, details about the hospitalization event (e.g., duration of influenza prior to hospitalization, acuity level during hospitalization, duration of hospitalization, complicating comorbid conditions, treatment) are unknown. These can be evaluated in future studies, but seem unlikely to affect the measurement properties of the instrument, although may result in a different scoring algorithm. Third, due to sample size limitations, stratified analyses by patient characteristics (e.g., sex, age) was not performed, but should be considered for future studies. Finally, while the content validity of the FLU-PRO has been established in children and adolescents through qualitative research, quantitative evaluation of measurement properties has not been conducted in these patient groups.</p>
              <p>Results of this study suggest the FLU-PRO may be useful as an outcome measure in clinical trials and epidemiological studies of disease due to non-influenza viruses. Although influenza is often indistinguishable from other viral infections in clinical practice, a standardized comprehensive symptom measure may be useful for exploring differences in the presentation and course of various viral infections. The FLU-PRO may also be used as an inclusion criteria for studies to ensure patients have sufficient symptoms to test treatment effects and recovery patterns. Future work also may evaluate the use of the FLU-PRO in prevention studies, such as vaccines, for disease due to various viruses including influenza.</p>
            </sec>
            <sec sec-type="conclusions" id="sec030">
              <title>Conclusion</title>
              <p>Results of this study suggest FLU-PRO scores are reliable, valid, and responsive to change in patients testing negative for the influenza virus, indicating the instrument can be used in studies of confirmed influenza and influenza-like illness.</p>
            </sec>
            <sec sec-type="supplementary-material" id="sec031">
              <title>Supporting information</title>
              <supplementary-material content-type="local-data" id="pone.0194180.s001">
                <label>S1 File</label>
                <caption>
                  <p><bold>Online supplement: Table A.</bold> Patient Demographic and Clinical Characteristics by Hospitalization Status (N = 220) <bold>Table B.</bold> FLU-PRO Domain and Total Score Descriptive Statistics in Non-Hospitalized Patients—Day 1 <bold>Table C.</bold> FLU-PRO Domain and Total Score Descriptive Statistics in Hospitalized Patients—Day 1 <bold>Table D.</bold> Two-day Reliability of FLU-PRO—Days 1 to Day 7 in Non-Hospitalized Patients <bold>Table E.</bold> Two-day Reliability of FLU-PRO—Days 1 to Day 7 in Hospitalized Patients <bold>Table F.</bold> Construct Validity: FLU-PRO Scale Correlations with Other PRO Measures at Day 1 in Non-Hospitalized Patients <bold>Table G.</bold> Construct Validity: FLU-PRO Scale Correlations with Other PRO Measures at Day 1 in Hospitalized Patients <bold>Table H.</bold> Known-Groups Validity: FLU-PRO Scores by Patient Global Rating of Disease Severity, Day 1 in Non-Hospitalized Patients <bold>Table I.</bold> Known-Groups Validity: FLU-PRO Scores by Patient Global Rating of Disease Severity, Day 1 in Hospitalized Patients <bold>Table J.</bold> Responsiveness of FLU-PRO by Patient Return to Usual Health (N = 119)<sup>1</sup> and Usual Activities (N = 67)<sup>2</sup>, Day 1 to Day 7 in Non-Hospitalized Patients <bold>Table K.</bold> Responsiveness of FLU-PRO by Patient Return to Usual Health (N = 50)<sup>1</sup> and Usual Activities (N = 50)<sup>2</sup>, Day 1 to Day 7 in Hospitalized Patients <bold>Table L.</bold> FLU-PRO Domain and Total Score Descriptive Statistics by Influenza Status—Day 1 <bold>Table M.</bold> 2-Way ANOVA of FLU-PRO Domain and Total Score by Influenza and Hospitalization Status—Day 1 <bold>Figure A.</bold> FLU-PRO Domain and Total Score by Diary Days 1 to 14: Non-Hospitalized Influenza-Negative Patients <bold>Figure B.</bold> FLU-PRO Domain and Total Score by Diary Days 1 to 14: Hospitalized Influenza-Negative Patients <bold>Figure C.</bold> FLU-PRO Domain and Total Score Descriptive Statistics—Day 1 <bold>Figure D.</bold> FLU-PRO Domain and Total Score Descriptive Statistics in Non-Hospitalized Patients—Day 1 <bold>Figure E.</bold> FLU-PRO Domain and Total Score Descriptive Statistics in Hospitalized Patients—Day 1 <bold>Figure F.</bold> Patient Global Rating of Flu Severity- Day 1 to 14.</p>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0194180.s001.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack>
              <p>We would like to extend sincere appreciation to staff providing research support at the clinical sites and to David Hengerer, Sandra Macker, and Hongyan Shen of Evidera for their assistance with data collection, management, and analyses; and to Amara Tiebout for her assistance with manuscript text edit and formatting. We also express our gratitude to the patients who gave of their time to help complete this study.</p>
            </ack>
            <ref-list>
              <title>References</title>
              <ref id="pone.0194180.ref001">
                <label>1</label>
                <mixed-citation publication-type="other">Centers for Disease Control and Prevention (CDC) (2016) Key Facts about Influenza (Flu) &amp; Flu Vaccine.</mixed-citation>
              </ref>
              <ref id="pone.0194180.ref002">
                <label>2</label>
                <mixed-citation publication-type="other">Centers for Disease Control and Prevention (CDC) (2016) Overview of Influenza Surveillance in the United States.</mixed-citation>
              </ref>
              <ref id="pone.0194180.ref003">
                <label>3</label>
                <mixed-citation publication-type="journal"><name><surname>Frost</surname><given-names>MH</given-names></name>, <name><surname>Reeve</surname><given-names>BB</given-names></name>, <name><surname>Liepa</surname><given-names>AM</given-names></name>, <name><surname>Stauffer</surname><given-names>JW</given-names></name>, <name><surname>Hays</surname><given-names>RD</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>What is sufficient evidence for the reliability and validity of patient-reported outcome measures?</article-title>
<source>Value in Health</source>
<volume>10</volume>: <fpage>S94</fpage>–<lpage>S105</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1524-4733.2007.00272.x">10.1111/j.1524-4733.2007.00272.x</ext-link></comment>
<?supplied-pmid 17995479?><pub-id pub-id-type="pmid">17995479</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194180.ref004">
                <label>4</label>
                <mixed-citation publication-type="journal"><name><surname>Revicki</surname><given-names>DA</given-names></name> (<year>2007</year>) <article-title>FDA draft guidance and health-outcomes research</article-title>. <source>Lancet</source>
<volume>369</volume>: <fpage>540</fpage>–<lpage>542</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0140-6736(07)60250-5">10.1016/S0140-6736(07)60250-5</ext-link></comment>
<?supplied-pmid 17307086?><pub-id pub-id-type="pmid">17307086</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194180.ref005">
                <label>5</label>
                <mixed-citation publication-type="journal"><name><surname>Rothman</surname><given-names>M</given-names></name>, <name><surname>Burke</surname><given-names>L</given-names></name>, <name><surname>Erickson</surname><given-names>P</given-names></name>, <name><surname>Leidy</surname><given-names>NK</given-names></name>, <name><surname>Patrick</surname><given-names>DL</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report</article-title>. <source>Value Health</source>
<volume>12</volume>: <fpage>1075</fpage>–<lpage>1083</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1524-4733.2009.00603.x">10.1111/j.1524-4733.2009.00603.x</ext-link></comment>
<?supplied-pmid 19804437?><pub-id pub-id-type="pmid">19804437</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194180.ref006">
                <label>6</label>
                <mixed-citation publication-type="journal"><collab>Food Drug Administration (FDA)</collab> (<year>2009</year>) <article-title>Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims</article-title>. <source>Fed Regist</source>
<volume>74</volume>: <fpage>65132</fpage>–<lpage>65133</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0194180.ref007">
                <label>7</label>
                <mixed-citation publication-type="journal"><name><surname>Osborne</surname><given-names>RH</given-names></name>, <name><surname>Norquist</surname><given-names>JM</given-names></name>, <name><surname>Elsworth</surname><given-names>GR</given-names></name>, <name><surname>Busija</surname><given-names>L</given-names></name>, <name><surname>Mehta</surname><given-names>V</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Development and validation of the influenza intensity and impact questionnaire (FluiiQ™)</article-title>. <source>Value in health</source>
<volume>14</volume>: <fpage>687</fpage>–<lpage>699</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jval.2010.12.005">10.1016/j.jval.2010.12.005</ext-link></comment>
<?supplied-pmid 21839407?><pub-id pub-id-type="pmid">21839407</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194180.ref008">
                <label>8</label>
                <mixed-citation publication-type="journal"><name><surname>Jacobs</surname><given-names>B</given-names></name>, <name><surname>Young</surname><given-names>NL</given-names></name>, <name><surname>Dick</surname><given-names>PT</given-names></name>, <name><surname>Ipp</surname><given-names>MM</given-names></name>, <name><surname>Dutkowski</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2000</year>) <article-title>Canadian Acute Respiratory Illness and Flu Scale (CARIFS): development of a valid measure for childhood respiratory infections</article-title>. <source>J Clin Epidemiol</source>
<volume>53</volume>: <fpage>793</fpage>–<lpage>799</lpage>. <?supplied-pmid 10942861?><pub-id pub-id-type="pmid">10942861</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194180.ref009">
                <label>9</label>
                <mixed-citation publication-type="journal"><name><surname>Powers</surname><given-names>JH</given-names></name>, <name><surname>Guerrero</surname><given-names>ML</given-names></name>, <name><surname>Leidy</surname><given-names>NK</given-names></name>, <name><surname>Fairchok</surname><given-names>MP</given-names></name>, <name><surname>Rosenberg</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2016a</year>) <article-title>Development of the Flu-PRO: a patient-reported outcome (PRO) instrument to evaluate symptoms of influenza</article-title>. <source>BMC Infect Dis</source>
<volume>16</volume>: <fpage>1</fpage>.<pub-id pub-id-type="pmid">26729246</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194180.ref010">
                <label>10</label>
                <mixed-citation publication-type="journal"><name><surname>Powers</surname><given-names>J</given-names></name>, <name><surname>Bacci</surname><given-names>E</given-names></name>, <name><surname>Leidy</surname><given-names>N</given-names></name>, <name><surname>Stringer</surname><given-names>S</given-names></name>, <name><surname>Kim</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>2016b</year>) <article-title>Evaluation of the Performance Properties of the Influenza Patient-Reported Outcomes Instrument (Flu-Pro)</article-title>. <source>Value in Health</source>
<volume>19</volume>: <fpage>A220</fpage>–<lpage>A221</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0194180.ref011">
                <label>11</label>
                <mixed-citation publication-type="book"><name><surname>Nunnally</surname><given-names>JC</given-names></name>, <name><surname>Bernstein</surname><given-names>IH</given-names></name> (<year>1994</year>) <chapter-title>Psychometric theory</chapter-title>
<publisher-loc>New York</publisher-loc>: <publisher-name>McGraw-Hill</publisher-name>
<fpage>xxiv</fpage>, 752 p. p.</mixed-citation>
              </ref>
              <ref id="pone.0194180.ref012">
                <label>12</label>
                <mixed-citation publication-type="journal"><name><surname>Cronbach</surname><given-names>LJ</given-names></name> (<year>1951</year>) <article-title>Coefficient alpha and the internal structure of tests</article-title>. <source>Psychometrika</source>
<volume>16</volume>: <fpage>297</fpage>–<lpage>334</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0194180.ref013">
                <label>13</label>
                <mixed-citation publication-type="book"><name><surname>Cohen</surname><given-names>J</given-names></name> (<year>1988</year>) <source>Statistical Power Analysis for the Behavioral Sciences</source>. <publisher-loc>Hillsdale, NJ</publisher-loc>: <publisher-name>Lawrence Erlbaum Associates Inc</publisher-name>,.</mixed-citation>
              </ref>
              <ref id="pone.0194180.ref014">
                <label>14</label>
                <mixed-citation publication-type="journal"><name><surname>Minodier</surname><given-names>L</given-names></name>, <name><surname>Charrel</surname><given-names>RN</given-names></name>, <name><surname>Ceccaldi</surname><given-names>PE</given-names></name>, <name><surname>van der Werf</surname><given-names>S</given-names></name>, <name><surname>Blanchon</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Prevalence of gastrointestinal symptoms in patients with influenza, clinical significance, and pathophysiology of human influenza viruses in faecal samples: what do we know?</article-title>
<source>Virol J</source>
<volume>12</volume>: <fpage>215</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s12985-015-0448-4">10.1186/s12985-015-0448-4</ext-link></comment>
<?supplied-pmid 26651485?><pub-id pub-id-type="pmid">26651485</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194180.ref015">
                <label>15</label>
                <mixed-citation publication-type="journal"><name><surname>Dunn</surname><given-names>JJ</given-names></name>, <name><surname>Gordon</surname><given-names>C</given-names></name>, <name><surname>Kelley</surname><given-names>C</given-names></name>, <name><surname>Carroll</surname><given-names>KC</given-names></name> (<year>2003</year>) <article-title>Comparison of the Denka-Seiken INFLU A.B-Quick and BD Directigen Flu A+B kits with direct fluorescent-antibody staining and shell vial culture methods for rapid detection of influenza viruses</article-title>. <source>J Clin Microbiol</source>
<volume>41</volume>: <fpage>2180</fpage>–<lpage>2183</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JCM.41.5.2180-2183.2003">10.1128/JCM.41.5.2180-2183.2003</ext-link></comment>
<?supplied-pmid 12734274?><pub-id pub-id-type="pmid">12734274</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194180.ref016">
                <label>16</label>
                <mixed-citation publication-type="journal"><name><surname>Ozdemir</surname><given-names>M</given-names></name>, <name><surname>Yavru</surname><given-names>S</given-names></name>, <name><surname>Baysal</surname><given-names>B</given-names></name> (<year>2012</year>) <article-title>Comparison of the detection of influenza A and B viruses by different methods</article-title>. <source>J Int Med Res</source>
<volume>40</volume>: <fpage>2401</fpage>–<lpage>2408</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1177/030006051204000639">10.1177/030006051204000639</ext-link></comment>
<?supplied-pmid 23321198?><pub-id pub-id-type="pmid">23321198</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
